AIE-featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment by Sarathkumar, Kothanahally S. et al.
Coordination Chemistry Reviews 447 (2021) 214135Contents lists available at ScienceDirect
Coordination Chemistry Reviews
journal homepage: www.elsevier .com/ locate/ccrReviewAIE-featured tetraphenylethylene nanoarchitectures in biomedical
application: Bioimaging, drug delivery and disease treatmenthttps://doi.org/10.1016/j.ccr.2021.214135
0010-8545/ 2021 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Abbreviations: ACQ, aggregation-caused quenching; AIE, aggregation-induced emission; TPE, tetraphenylethene; AIEE, AIE enhancement; OLEDs, organic light-
diodes; PDT, photodynamic therapy; ALP, alkaline phosphatase; GSH, glutathione; COF, covalent organic framework; HOF, hydrogen-bonded organic framework; MO
organic framework; Cys, cysteine; Hcy, homocysteine; Gal, D,galactose; LAP, leucine aminopeptidase; PNPs, polymeric nanoparticles; ROMP, ring opening me
polymerization; DEDA, N-,N-diethylehtlenediamine; SDS, sodium dodecyl sulfonate; ROS, reactive oxygen species; ICT, intramolecular charge transfe
dichloromethane; OPEF, one-photon excited fluorescence; TREF, two-photon excited fluorescence; Ser, serine; Asp, aspartic acid; PTPA, poly(N,N-diphenyl 1-4-(
triphenylvinyl)styryl)aniline); MHNS, mesoporous silica hollow nanospheres; anti-EpCAM, anti-epithelial cellular adhesion molecule; GTMS, c-glycidoxypropyltr
ysilane; PTZ, phenothiazine; TICT, twisted intramolecular charge transfer; MDR, multidrug resistant; AMO, amoxicillin; EDA, 1,2-ethane diamine; PGEDA, pol
methacrylate; LTA, lipoteichoic acid; PSs, photosensitizers; NIR, near-infrared; DC, dicyanovinyl; FR, far red; DCFDA, dichlorofluorescenceindiaacetate; Cbl, chloramb
photodynamic inactivation; EPR, enhanced permeability and retention; MMC, mitomycin C; BSO, buthionine sulfoximine; PTX, paclitaxel; PEG, polyethylene gly
dimethylmaleic anhydride; GO, gene ontology; KEGC, Kyoto encyclopaedia of genes and genomics.
⇑ Corresponding authors at: Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru, India (K. S. Sharath Kumar). NanoBioCel Researc
School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain (Gorka Orive). Institution of Excellence, Vijnana Bhavan, University of
Manasagangotri, Mysuru, India (K. S. Rangappa).
E-mail addresses: sharathrsh@chemistry.uni-mysore.ac.in (K.S. Sharath Kumar), gorka.orive@ehu.eus (G. Orive), rangappaks@ioe.uni-mysore.ac.in (K.S. Rangapp
1 Contributed equally.Kothanahally S. Sharath Kumar a,1,⇑, Yarabahally R. Girish b,1, Milad Ashrafizadeh c,d,1, Sepideh Mirzaei e,
Kadalipura P. Rakesh f, Mohammad Hossein Gholami g, Amirhossein Zabolian h, Kiavash Hushmandi i,
Gorka Orive j,k,l,m,⇑, Firoz Babu Kadumudi n, Alireza Dolatshahi-Pirouz o, Vijay Kumar Thakur p,q, Ali Zarrabi d,
Pooyan Makvandi r, Kanchugarakoppal S. Rangappa s,⇑
aDepartment of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru 570006 India
bCentre for Research and Innovations, School of Natural Sciences, BGSIT, Adichunchanagiri University, B. G. Nagara, Mandya 571448, India
c Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanlı, Tuzla, 34956 Istanbul, Turkey
d Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956 Istanbul, Turkey
eDepartment of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran
f School of Material Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea
g Faculty of Veterinary Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Iran
hYoung Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
iDepartment of Food Hygiene and Quality Control, Division of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
jNanoBioCel Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain
kUniversity Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria-Gasteiz, Spain
lBioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain
m Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, Singapore
nDepartment of Health Technology, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
oDepartment of Health Technology, Technical University of Denmark, Center for Intestinal Absorption and Transport of Biopharmaceuticals, 2800 Kgs. Lyngby, Denmark
pBiorefining and Advanced Materials Research Center, Scotland’s Rural College (SRUC), Kings Buildings, Edinburgh EH9 3JG, UK
qDepartment of Mechanical Engineering, School of Engineering, Shiv Nadar University, Uttar Pradesh 201314, India
r Istituto Italiano di Tecnologia, Centre for Materials Interfaces, Viale Rinaldo Piaggio 34, 56025 Pontedera, Pisa, Italy
s Institution of Excellence, Vijnana Bhavan, University of Mysore, Manasagangotri, Mysuru 570006, Indiaa r t i c l e i n f o
Article history:
Received 12 May 2021
Accepted 14 July 2021
Available online 17 August 2021
Keywords:
Tetraphenylethylenea b s t r a c t
The development of aggregation-induced emission (AIE) has received extreme considerations from basic
and clinical researches. To date, various luminogens with AIE property (AIEgens) have been broadly uti-
lized in optoelectronic devices, fluorescent bio-probes, drug delivery, anticancer and chemosensors and
many more. Scientists have likewise dedicated to investigating the possibilities of AIEgens in the biomed-
ical field. Among the various AIE luminophores studied, tetraphenylethylene (TPE) derivatives have
demonstrated as most promising AIEgen, owing to their capacity in self-organization and conjugation
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Luminogens
Biomedical applicationsFig. 1. Representing AIE pIt likewise generally utilized in different fields, like organic and therapeutic science, supramolecular
chemistry, organic electronics, cancer therapy, apoptosis and inflammation, microorganism imaging ther-
apy etc. This review encompasses the recent advances of TPE based AIE-active luminophores and their
potential applications in biomolecular science.
 2021 The Authors. Published by Elsevier B.V. This is an open access articleunder the CCBY license (http://
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During the past few decades organic materials that emit fluo-
rescence in the condensed and solid-state is of great attention in
various fields such as in chemo-/bio-sensors, detection of cancer
cells, bio-imaging, drug delivery etc [1–5], due to their high photo-
stability and excellent fluorescent quantum yields [6,7]. Despite of
the development of these luminescent materials, an infamous phe-
nomenon emerges called aggregation-caused quenching (ACQ),
which potentially restricts many applications including optoelec-
tronics and biology [8]. ACQ is a phenomenon wherein the emis-
sion of fluorophores in solid-state or in suspension is quenched
because of aggregate formation. This can be attributed to that most
of the organic luminogens have rigid and planar molecular struc-
tures and strong affinity of intermolecular p-p stacking interac-
tions in the condensed form. Thus, these luminogens follow a
non-radiative relaxation pathway, resulting in emission
annihilation.
Tang et al. [12] first time found a phenomenon exactly opposite
to that of ACQ photophysical properties based on propeller-shaped
silole organic moiety, and was named as aggregation-induced
emission (AIE). After that, AIE material has become a hot topic of
anti-ACQ materials where the non-luminescent materials in the
molecularly solutions are made to emit strong fluorescence when
it is in the condensed state or in the aggregated state [13]. The
AIE mechanism is demonstrated in Fig. 1, the mechanism of AIE
is amalgamated as the restriction of intramolecular rotations
(RIR) in the aggregations due to various intermolecular interac-
tions, which help to design AIE luminogen of high luminescence.henomenon of propeller-shaped T
2
Park et al [14] further discovered one more concept named
aggregation-induced emission enhancement (AIEE), where
luminogens exhibit emission both in solution and solid, as well
as in the aggregated state. To understand the mechanistic pathway,
various research groups have proposed different mechanisms
including conformational planarization, excited intermolecular
proton transfer, twisted intermolecular charge transformation,
and E/Z isomerization [15,16]. However, all these mechanisms
were not supported by experimental evidence. Tang et al [17] in
2014 have attributed the AIE effect to the RIR of molecules effect
upon aggregation due to intermolecular interactions between the
AIE molecules. Further, this phenomenon is most important to
address ACQ problems, as AIE luminogens show the highest
fluorescence intensity, better photostability, turn on fluorescence,
and larger stroke shift as illustrated in (Fig. 2) encouraging
researchers to develop and to construct solid state emitters in
practical applications in organic light-emitting diodes [18] and
chemo/biosensors [19] for biological imaging and monitoring of
biological processes.
In recent times, there are large numbers of luminogens in the
literature with AIE/AIEE characteristics. These include TPE, siloles,
napthalimide, anthracene derivatives, carbazoles, cyanostilbenes,
phenothiazines, boron-dipyrromethene derivatives (BODIPY),
diphenyldibenzofulvenes, organoboron, pyrene derivatives, pyra-
zine derivatives, metal complexes, etc [13,20–24]. TPE is consid-
ered as a promising building block for forming macrocycles and
cages [25], and it is the most extensively studied AIEgen because
of self-organisation capability and their compatibility with ACQ
fluorophores [26]. Moreover, TPE derivatives have benefited asPE luminogen in solution and aggregated state [9–11].
Fig. 2. Possible applications of AIE active TPE derivatives.
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ing from the mechanical stimuli excitation. The molecular struc-
ture of TPE is non-planar and possesses highly dynamic groups.
TPE luminophores are non-emissive in solutions due to free rota-
tion of the four phenyl rings around doubly bonded carbon atoms
in the TPE molecule, causing a non-radiative relaxation process.
The propeller-shaped conformation of TPE molecule restricts theScheme 1. Synthetic route of te
3
intramolecular rotation of the benzene rings upon aggregation.
This shaped restriction of intramolecular rotation [27] results in
prevention of non-radiative relaxation pathway and therefore
TPE emits high fluorescence (Fig. 1).
To date, there have been several TPE derivatives in the literature
with high fluorescence quantum yield with aid of functionalizing
TPE with pyrene, anthracene, carbazole, triphenylamine, perylene,
organoboron, BODIPY luminogens and used in various fields with
potential applications (Fig. 2) [28–36]. Because of ease functional-
ization, TPE can be synthesized by various synthetic routes and are
summarized in Scheme 1 [37–45]. TPE luminogens and its deriva-
tives have been used in various applications such as mechanofluo-
rochromic materials [46], OLEDs [47], chiral applications [48], solar
cells [49], bio probes [50], biosensors [51], cell imaging [52] and
drug delivery.[53]
Many efforts have been made to summarize the developments
and applications of AIEgens. More recently, Xiaolei Cai and Bin
Liu [54] reviewed recent advances in materials and biomedical
applications of AIEgen focusing on design strategies and seldom
discussed the biomedical applications. In this review, we offer a
systematic summary on the fundamentals of TPE-based AIE
luminogens and in-depth analysis of its applications in biomedi-
cine. Our focus was put on the recent advances of the TPE-based
probes for sensing biomolecules (alkaline phosphatase, ATP, cys-
teine, b-galactosidase, leucine aminopeptides, lipase etc.), ions
detection (Cu2+, Fe3+, Hg2+, Ag2+, Zn2+ etc), bio imaging (at the cel-
lular level), detection and inhibition of drug resistant bacteria
(MRSA), cancer diagnosis (in cell lines and animal models),
chemo-photodynamic therapy and imaging-guided drug delivery.
In each of these sections, we brief the synthetic route of the probe,
action of mechanism and its advantages. Lastly, we covered the
perspective based on the understanding of overall developments,
exploring the limitations and the more possible biomedical appli-
cations of TPE AIEgens.traphenylethylene (TPE 1).
Fig. 3. Structure of 10. (a) FL emission spectra of 10-PPi complex (20 M) in Tris-HCl
(pH 7.4) incubated with different ALP concentrations at 37 C; (b) linear relation-
ship of the FL intensity with ALP concentrations at 470 nm; (c) FL emission under a
365 nm lamp; (d) FL intensity of 10-PPi complex (20 M) with various enzymes
(50 mU mL1) in Tris-HCl (pH 7.4). Reproduced with permission from [61].
Copyright 2018 Elsevier.
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Fluorescent sensing of biomolecules has attracted considerable
attention for diagnosing several diseases including Alzheimer’s dis-
ease, liver disfunction, osteoblastic bone cancer, prostate cancer,
breast cancer and diabetes [55–60]. TPE-based fluorescent mole-
cules with AIE characteristics have been recently developed as a
potential method for sensing biomolecules like alkaline phos-
phatase (ALP), cholera toxin, glutathione (GSH), b-galactosidase,
lipase and many more [61–65].
ALP is a protein enzyme and plays an important role in catalys-
ing biochemical processes including dephosphorylation of phos-
phate ester, DNA, and proteins as well as in regulating cellular
events of the cell cycle, growth, apoptosis, and signal transduction
pathways [66,67]. So far, various methods are available for detec-
tion of ALP such as colorimetry, electrochemiluminescence, fluo-
rometry, surface-enhanced Raman scattering, and
chromatography etc [68–72]. TPE-based probe for biosensing has
gained considerable attention for detection of ALP due to its high
sensitivity and specificity. Wei Liu et al [61] have shown that
AIE-active TPE based turn-on probes are effective for selective
biosensing of ALP and pyrophosphate (PPi). Here, with
diethylenetriamine-functionalized tetraphenylethylene probe 10
reaction with PPi creates an intermolecular self-assembly via
hydrogen bonding between NH2 groups of 10 and oxygen atoms
of PPi and turn-on aggregation induced emission. Further introduc-
tion of ALP leads to hydrolysis of PPi to orthophosphate (Pi) turned
off the fluorescence emission. This was the first example to use PPi-
triggered AIE phenomenon for the ALP analysis and the detection
limit was 0.09 mU mL1 and 66.7 nM for ALP and PPi, respectively
(Fig. 3).
Ai-Xiang Ding and colleagues [73] reported high selective and
sensitive fluorescence probe to detect Cu2+ and ATP in water med-
ium using a TPE amphiphile (11) which can generate AIE micelles
in an aqueous solution (Fig. 4). A significant fluorescence quench-
ing results from 11 and Cu2+ interaction, however fluorescence
capacity can be immediately restored after addition of ATP from
the in situ generated 11-Cu2+ complex. The AIE active amphiphilic
probe as hydrochloride 11 was analysed in THF/water mixture and
the formation of micelles was identified by TEM. Both 11 and 11-
Cu2+ complexes were able to effectively image the Cu2+ and ATP
in living HepG2 cells due to their sensitive fluorescence response
towards analyte and showed high biocompatibility. These AIE
micelles showed superior activity as interfacial chemosensor and
sensing specific analyte and could become a new way for the
development of an artificial sensor.
Intercellular thiols like GSH, homocysteine (Hcy) and cysteine
(Cys) play a crucial part in the biochemical process [74,75]. Defi-
ciency of cystine in humans leads to several health problems
including depigmentation of hair, slowed growth in children,
edema, liver damage, fat and weakness [76–78]. Various available
analytical methods including HPLC, UV–vis and fluorescence spec-
troscopy for detection of Cys suffer from one or the other disadvan-
tages [79–82]. Therefore, there is a need for a fluorescent probe
that could selectively detect Cys in high sensitivity and selectivity
because of its biological importance. Guoyu Jiang et al [63]
designed and synthesized 2,4-dinitrobenzenesulfonyl functional-
ized TPE derivative 12 for biosensing Cys in PBS over Hcy and
GSH with high specificity (Fig. 5). Synthesized probe 12 exhibited
a weak emission in PBS buffer, whereas upon addition of Cys, the
probe came in contact with the thiol group of Cys, which promoted
cleavage of the 2,4-dinitrobenzenesulfonyl group in 12, leading to
the generation of fluorescence in 13. The authors further carried
out nucleophilic substitution reaction with other biologically
important amino acids including Hcy and GSH, unfortunately they4
didn’t find any fluoresce enhancement. All these results suggest
that 2,4-dinitrobenzenesulfonyl functionalized TPE derivative 12
is highly selective and sensitive probe for biosensing Cys over
Hcy and GSH.
In 2017, Guoyu Jiang et al [64] reported that partially water sol-
uble TPE derivative by conjugation of positively charged pyri-
dinium pendant with D-galactose (Gal) 14 as fluorescent probe
can be used for light-up imaging sensor of endogenous b-
galactosidase detection in live cells (Fig. 6). b-galactosidase is an
enzyme catalysing the hydrolysis of b-galactosides into monosac-
charides by disrupting glycosidic linkage and its deficiency result
in Morquio B syndrome. TPE-Gal (14) separated the b-
galactopyranoside sugar moiety in the presence of an enzyme b-
galactosidase resulting an intermediate phenolate to generate
pyridine-substituted TPE 15 by elimination of p-quinone-
methide. The formed derivative 15 is poorly soluble in water due
to generation of aggregates and results in turn on fluorescence.
This TPE-Gal (14) has unique features than traditional ACQ probes
including high specificity, low toxicity toward b-galactosidase, and
high cell permeability making them to find potential applications
in cancer diagnosis.
Leucine aminopeptidase (LAP), which is a vital exo-pepetidase
can hydrolyse N-terminal proteins in plants and animals. LAP has
served as a biomarker for liver and pancreas related diseases.
Recently, Shuailing Huang and co-workers [83] reported and syn-
thesized TPE substituted DPA-TPE-Leu (16) derivative used for
Fig. 4. Structure of 11. (A) Fluorescence spectra of 11 in THF (monomers), aqueous solutions (micelles) and hydrochloride in THF (aggregates); (B) Plot of 491 nm versus
concentration (inset displays photographs of 11 under 365 nm UV light illumination); (C, D) TEM image and size distribution of 11 in water. Reproduced with permission
from [73]. Copyright 2018 Elsevier.
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tive 16 is hydrophilic and undergoes cleavage by LAP, leading to
the formation of hydrophobic aggregate DPE-TPE-OH (17). The
study found that endogenous LAP has excellent photostability,
low toxicity, good solubility with a detection limit of 0.16 UL1.
Further, this endogenous LAP could be utilized for live-cell imaging
of HepG2 xenograft tumour.
Lipase is a glycoprotein that its level in serum serves as an
imperative biomarker for diagnosis of the acute pancreatitis and
the disorders of pancreas. Hence, the development of probe for
sensing lipase is crucial in the detection of pancreatic diseases.
Recently Shi and co-worker [84] developed a fluorescent probe
based on glutamate functionalized TPE 18 with turn-on AIE-
activity for detection of lipase (Fig. 8). The as-synthesized gluta-
mate functionalized TPE derivative 18 contains amino and car-
boxylic moieties as hydrophilic groups and in the presence of
lipase, it facilitates the hydrolysis of glutamate group of TPE (18)
at the oil–water interface resulting in aggregation of TPE-2OH
derivative 19 which gives strong blue emission. Such a probe is
appropriate for the lipase level up to 80 UL1 in humans and lowest
detection limit found as 0.13 UL1. Therefore, this probe is found to
be a benefit for conducting the pathological analysis of disease
involving the lipase enzyme.
Spermine is a natural polyamine biosynthesized by enzymatic
decarboxylation of amino acids and exerts crucial role in cell
growth and proliferation. Notably, enhanced levels of spermine5
are considered as risk factors for malignant tumor development.
The lack of efficient probes for selective identification of spermine
provoked Guoyu jiang and coworkers [85] to construct a
supramolecular structure probe via electrostatic interactions
between cationic and amphiphilic TPE AIEgen and cucurbit[7]uril
(CB7) for biodetection of spermine over spermidine. Free rotation
of phenyl rings in aqueous solution makes 20 to be less emissive
and fluorescence is turned on upon incorporation of CB[7] to 20
due to restricted rotation (Fig. 9). Addition of spermine which com-
petitively binds to CB[7], affects the release of 20 and gives OFF sig-
nal. Similarly other fluorescent probe 22 is fabricated in a similar
approach using 1-adamantanamine (AD) [CB8]. Selectivity chal-
lenge of 21 is conducted using different polyamines, and fluores-
cence intensity was vastly quenched in spermine whereas no
detectable variation in the intensity for other amines except that
spermidine affects slight decrease than spermine. Incorporation
of CB[8] into 20 induced large aggregate formation along with
restricted rotation of phenyl ring which is evident by fluorescent
imaging experiments (Fig. 9E).
The detection and analysis of DNA are worth aspect in diagnos-
ing genetic diseases and to monitor biological processes. Fluores-
cence assays based on AIE effect are best among the label-free
DNA sensors, especially when AIEgens are featured with positive
charge(s) show electrostatic attraction towards DNA to form aggre-
gates. Thus cis-TPE macrocycle diammoniums with two ammo-
nium arms in cis (23 and 24) and geminal (25 and 26) positions
Fig. 6. Structures of 14 and 15 and revealing light-up sensing of b-galactosidase. (A) Fluorescence emission spectra of 14 (inset displays the photographs of 14 with and
without b-galactosidase in 365 nm UV light); (B) Fluorescence intensity at 512 nm with various concentrations of b-galactosidase (inset displays linear plot of fluorescence vs
b-galactosidase concentration at 512 nm). Reproduced with permission from [64]. Copyright 2017. The Royal Society of Chemistry.
Fig. 5. Structures of 12 and 13 and schematic illustration of light-up sensing of Cysteine by 12. (A) The fluorescence responses of 12 (25 lM) in PBS towards various
biomolecules; (B) Bar graph of response of 12 (25 lM) in PBS towards Cys, Hcy, GSH, and other amino acids. Reproduced with permission from [63]. Copyright 2017 Elsevier.
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Fig. 7. Structures of 16 and 17 and schematic illustration of probe 16 (A) Fluorescence spectra of 17 in THF/water mixture; (B) fluorescence intensity of 17 at 505 nm as a
function of water fraction; (C) photographs of 17 in THF/water at 365 nm. Reproduced with permission from [83]. Copyright 2018 Elsevier.
Fig. 8. Structures of 18 and 19 and schematic representation of sensing mechanisms of probe 18 in detection of lipase. (A) I/I0 value of probe 18 vs lipase samples (fixed
concentration); (B) Fluorescence photograph of probe 18with human serum samples. Reproduced with permission from [84]. Copyright 2017. The Royal Society of Chemistry.
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Fig. 9. Structures of 20–22. (A) Fluorescent images of 20; (B) 20 + CB[7]; (C) 20 + CB[7] + Spermine; (D) 20; (E) 20 + CB[8] and (F) 20 + CB[8] + AD (in H2O containing 1%
DMSO). The concentrations of 20, CB[7], Spermine, CB[8], AD are 5 M, 20 M, 20 M, 10 M and 20 M, respectively. Reproduced with permission from [85]. Copyright 2018
Elsevier.
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and 24 displayed bisignate CD signals upon addition to calf thymus
DNA (CT-DNA), indicating the robust DNA induction and the stable
immobilization in propeller-like conformation of TPE (Fig. 10A). In
contrast, there are no bisignate bands for geminal isomers suggest-
ing more TPE unit flexibility than in the cis counterparts when they
bind with DNA (Fig. 10B). In addition, TPE diammoniums used to
sense DNA and interestingly cis-TPE ammoniums were more sensi-
tive than geminal isomers, besides 24 displays higher sensitivity
than 23 for detection of FS-DNA and CT-DNA probably due to the
overlapping distance of two ammonium arms in 24 isomer with
two phosphate anions in the DNA double-helical chain. This ultra-
sensitive DNA detection by cis-TPE macrocycle diammoniums is
attributed to the AIE mechanism of restriction of double-bond
rotation (RDBR) in the excited state.8
3. TPE-based fluorescent sensors for detection of ions
Identification and assessment of metal ions play a key role in
environmental and biological investigations [87,88]. For example,
zinc (Zn2+), silver (Ag+), and mercury (Hg+) ions are involved in var-
ious pharmacological studies, such as antimicrobial, antitumor,
anticancer, and other bio-molecular science therapy [89–91]. In
general, TPE analogue only acts as an AIE-fluorophore [92], there-
fore detecting ions in the media requires a chelating/binding group
in TPE derivatives. Various TPE derivatives have been studied in the
literature for detecting ions such as Cu2+, Fe3+, Hg2+, Ag+, F, CN,
NO3 etc. and utilised as an alternative to chemosensors.
In another work, Yuming Zhao et al [93] developed a pH-
triggered self-assemblies of polymeric nanoparticles (PNPs) with
Fig. 10. Structures of 23–26. Computational simulations of the binding of (A) 24 and (B) 26 to a DNA strand. Reproduced with permission from [86]. Copyright 2020 American
Chemical Society.
Fig. 11. Synthesis of poly(M1)-b-poly(M2-co-M3) block copolymer 27 with pH-response AIE activity. Reproduced with permission from [93]. Copyright 2016 The Royal
Society of Chemistry.
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Fig. 12. Structure of 28 and representation of fluorescence nanoprobe 28 for sequential recognition of SDS and ClO. Reproduced with permission from [94]. Copyright 2019
Elsevier.
Fig. 13. Structure and sensing mechanism of 29 for detection of Zn2+ and PPi ions. Reproduced with permission from [95]. Copyright 2018 Elsevier.
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Fig. 14. Structure of ligand 30 and self-assembled illustration of Metal-Organic Nanobelt 31. Fluorescence responses of complex 31 in 2 mL of CH3CN/ H2O at 298 K (v/v, 1/1;
c = 7.04  106 M); (A) Photographs (kex = 365 nm) and (B) Relative fluorescence intensity of after and before addition of 4.0 lmol interfering species. Reproduced with
permission from [96]. Copyright 2020 American Chemical Society.
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Towards this, they have synthesised polymer 27 by ring-opening
metatheses polymerization (ROMP) technique, where hydrophilic
M1 contains a PEG side chain and reactive pentafluorophenyl and
an AIE active TPE ester in hydrophobic M2-co-M3. Here, the self-
assemblies were started by the aggregation of hydrophobic micro-
domains of poly(M2-co-M3) blocks which is further cross-linked
by reacting with diamine to produce stable PNPs. The cross-
linked PNPs were further post functionalized with diethylamino
or carboxylic group by reacting with N, N-diethylethylenediamine
(DEDA) and b-alanine, resulting in pH tunable fluorophores in
water with weak fluorescence above pH 10 and strong fluorescence
below pH 8. Moreover, the turn on/off fluorescence property of
functionalized PNPs was obtained by varying pH between 2 and 11.
The synthesis of TPE based AIE active cationic organic building
block 28 as nano-probe for sodium dodecyl sulfonate (SDS) and
hypochlorite (ClO) detection in water was reported by Zhan Zhou
et al (Fig. 12) [94]. The luminophore 28 exhibited poor fluorescence
emission in water and the emission could be enhanced six-fold by
treating with SDS as a surfactant (average size of 45 nm). More
importantly, a switch on–off fluorescence has been observed upon
addition of ClO and this could allow determining the accurate
concentration of reactive oxygen species (ROS).11In 2018 Chang and Lee [95] reported fluorescent micellar probe
for Zn2+ and pyrophosphate ions (PPi) detection, which contains a
TPE derivative as an AIEgen and a chelating fluorophore dipicoly-
lamine (DPA)-naphthalimide. The micellar probe was formed by
mixing with sodium dodecyl sulfate (SDS) (Fig. 13). When exciting
at 341 nm, this micellar probe 29 displays a very weak blue fluo-
rescence at 482 nm which is attributed to the AIEgen property of
the TPE, where the chelating fluorophore was inactive due to
photo-induced electron transfer (PET) from DPA to naphthalimide.
However, the probe 29-Zn exhibits a strong green fluoresce at
530 nm in presence of Zn2+ due to suppression of PET impact indi-
cating the chelation of Zn2+ with DPA. Moreover, after chelation
with Zn2+ the probe showed a strong affinity to PPi that affects
the change in fluorescence intensity from 530 to 474 nm due to
the possible rearrangement of Zn2+ ions with PPi. The detection
limit found to be 46 and 88 nM for Zn2+ and PPi ions, respectively
in the 5–10 pH range. Thus, TPE linked fluorescent micellar probe
demonstrated as promising agents for imaging Zn2+/PPi related
physiological responses.
Metal-organic supramolecular nanobelt bearing AIE active TPE
core as a turn-on fluorescence sensing probe for sulfide ion (S2)
was designed by Kaixiu Li et al (Fig. 14) [96]. An AIE active TPE
based tetrapodal ligand was synthesized, which formed a self-
Fig. 15. Structure of 32. (A) PL spectra of 32 in presence of metal ions with 1.67  104 M concentration in THF and THF/water system (fw = 70%); (B) Photographs of the
mixtures of 32 (10  106 M) with different metal cations at 365 nm; (C) Fluorescence images of HeLa and MCF-7 cells. Reproduced with permission from [97]. Copyright
2018 WILEY-VCH Verlag GmbH & Co.
K.S. Sharath Kumar, Y.R. Girish, M. Ashrafizadeh et al. Coordination Chemistry Reviews 447 (2021) 214135assembled nanobelt by complexing with Cd2+. The presence of TPE
moiety in the terpyridine ligand 30 makes strong emission in the
aggregated state, but emission was turned-off in both aggregation
and solution states after formation of the nanobelt 31. Interest-
ingly, the complex 31 underwent structural transformation to 30
and turned on its fluorescence property in alkaline solution or in
presence of S2. This reversible transformation is due to the cad-
mium salt formation, therefore the metal–organic nanobelt 31
can be utilised as a turn-on sensor to detect S2 ions. Moreover,
the complex 31 tested with the addition of various metal salts in
CH3CN/H2O mixture, the complex shows a specific emission
enhancement with Na2S, indicating that the complex 31 possesses
a stimuli responsive emission specifically to S2 ions.
In 2018 Xing Feng et al [97] designed a pyridinyl-functionalized
TPE derivative for specific detection of Fe3+ ions in THF/water mix-
ture (Fig. 15). This turn-on fluorescence probe can identify only
Fe3+ ions in presence of various cations even at concentrations of
up to 1.67  104 M, leading to fluorescence emission changes to
strong red from weak blue in Fe3+ ions. Further, only hydrolysed
Fe3+ among different metal ions with pKa (3.20) was lower than
32 pKa (3.27) and can induce protonation of 32 in water, owing12to different solubility products of the other metal ions, it is improb-
able to decrease the pKa to 3.27 and protonate 32 in aqueous solu-
tion. The pH-dependent sensitivity and selectivity of 32 to detect
Fe3+ is observed in vitro cellular imaging of HeLa and MCF-7 cancer
cells. HeLa cells which are incubated with 32 and without Fe3+
emitted deep blue fluorescence, and blue and red fluorescence
emitted simultaneously in the presence of Fe3+. Increased red fluo-
rescence intensity was observed with elevated Fe3+ concentration
suggesting a potential utility of 32 as ratiometric fluorescence
probe for detection of Fe3+ in live cells.
Porous materials have potential impact in chemical sensing,
introduction of AIEgens into various porous crystalline materials
including covalent organic framework (COF), hydrogen-bonded
organic framework (HOF), metal organic framework (MOF) etc.
providing a new fluorescence materials with enhanced sensing
properties. Yingting Zheng and co-workers [98] have fabricated
1,3,5-triazine containing porous tetraphenylene-based organic
polymer (PTOP) 33 (Fig. 16) possessing large chelating areas
for metal ions, in which TPE AIEgen synergise the porous struc-
ture for sensing Fe(III). The fluorescence of 33 is completely
quenched in presence of Fe3+ (Fig. 16a), this selective fluores-
Fig. 16. Structure of 33. (A) Quenching efficiency of 33; (B) Time-dependent emission intensity of 33 immersed in a MeOH solution of Fe3+ ion; (C) Emission spectra by the
gradual addition of a Fe3+ methanol solution; (D) Ksv curve of 33 immersed in MeOH solutions of Fe3+ ion with different concentrations. Reproduced with permission from
[98]. Copyright 2020 Elsevier.
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paramagnetism. Quenching sensitivity experiment gives KSV of
5.6 mM1 (Ksv: the quenching constant) for 33 (Fig. 16d) with
limited detection concentration of 4.5 mM for Fe3+ fluorescence
sensing based on 3r/Ksv equation (r: standard deviation). The
quenching mechanism of 33 by Fe3+ is through the insertion of
Fe3+ within the pores of 33.13Detection of Al3+ ions is of great importance as its accumulation
induces many disorders. Fluorescence chemosensors got much
attention for the detection of various analytes including Al3+ than
conventional detection techniques. COF-based on the tetrakis-(4-
aminophenyl)ethane and 2,5-dihydroxyterephthaladehyde (COF-
DHTA) 34 (Fig. 17) was employed by Jian Xiu and co-workers
[99] to selectively detect Al3+ ions. COF-DHTA 34 dispersed uni-
formly in most of the solvents and exhibited stronger fluorescence
Fig. 17. Schematic illustration of 34 (COF-DHTA). (A) The fluorescence spectra of 34 in different solvents; (B) The fluorescence spectra of 34 in different metal ions (40 lmol/
L); (C) The fluorescence spectra of 34 in the presence and absence of Al3+ ions and EDTA; (D) Competitive experiments of 34 in DMF in the presence of Al3+ ions and the various
metal ions (40 lmol/L), respectively. Reproduced with permission from [99]. Copyright 2021 Elsevier.
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enhanced upon addition of Al3+ions than any other metal ions
(Fig. 17b), attributed to the synergetic impact of COF pore and
the coordination of nitrogen and oxygen on the 34 with Al3+ ion.
The complexing process of 34 with Al3+ ions found to be coordina-
tion process and reversible (Fig. 17c). The sensitivity of 34 towards
Al3+ doesn’t affected in presence of other metal ions (Fig. 17d).4. TPE based AIE luminogens for bioimaging
Fluorescence imaging of cells has been extensively used for
biomedical applications today because of its unique feature to
visualize biological process inside the cell [100]. So far, various
bio-imaging techniques including molecular imaging, photon14emission computing tomography and MRI techniques are utilized
for visualization of live cells, tissues, and molecules in living organ-
isms [101–105]. Among various bioimaging techniques, fluores-
cent imaging is the most common approach that has gained
considerable attention because of its photostability, low cytotoxic-
ity, and biocompatibility. During last few decades, a range of fluo-
rescent probes including carbon dots [106], semiconducting
polymer nanoparticles, 2D-nanomaterials, metal nanoclusters,
organic dyes, supramolecular (assembled) organic substances,
semiconducting quantum dots etc [107–111] have been success-
fully developed and utilized for biomedical applications [19].
Recently, AIE turn-on fluorescent probes have gained much atten-
tion and successfully utilized for real-time imaging [112], long
term cell tracking [113], organelles [114], tracing cell process
[115], roles of biomolecules in living system [116–118],
Fig. 18. Structure of 35. (A) Fluorescence images of HeLa cells stained with 35 and MTG; (B) I/Io plot value of HeLa cells stained with 35 and MTG. Reproduced with
permission from [122]. Copyright 2019 American Chemical Society.
Fig. 19. Structure of 36 and 37. (a–c) CLSM images of MitoTracker Deep Red FM with 36 and 37; (d–f) in A549 cancer cells; (a, d) Mito Tracker stained mitochondrial
fluorescent image; (b, e) Fluorescent image of mitochondria stained by 36 & 37; (c) An overlay image of (a) & (b); (f) an overlay image of (d) & (e). Reproduced with permission
from [123]. Copyright 2020 The Royal Society of Chemistry.
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Fig. 20. Schematic mechanism of detection of GlcNAc-TPE (38) and Py-TPE (15). (A) LysoTracker Green DND-26; (B) GlcNAc-TPE (38); (C) A and B merged images; (D)
Fluorescence intensity profiles along the white line; (E-G) CLSM images of cells stained with 38; (H) Average intensity of cells stained with 38 in the absence and presence of
PUGNAc. Reproduced with permission from [124]. Copyright 2019 American Chemical Society.
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compatible and affordable and can be utilized for detection of can-
cer cells [121].
Xiujie Zhao and co-workers [122] reported near-infrared TPE–
Xan–In (35) as a turn-on AIE-active probe consisting of TPE with
a NIR merocyanine unit (Xan-In) for long-term mitochondrial
tracking. The as-synthesized TPE–Xan–In (35) is explored for AIE
characteristics at different pH levels in the THF-water system. It
was observed that the TPE–Xan–In (35) at pH < 6.0 in 70% water
is non-emissive and hardly aggregates due to formation of pheno-
late ion, whereas at pH greater than 6.0, especially at 7.0 the probe
is highly emissive and forms aggregates due to generation of phe-
nolic form, which could be ascribed to the AIE characteristics. The
authors have carried out cytotoxicity assay of HeLa cells by treating
TPE–Xan–In (35) up to 100 lM concentration for 48 h and showed
that the cells are viable. Further, authors have carried out photoox-
idation stability of the probe TPE–Xan–In (35) by scanning the
stained HeLa cells for various times and monitoring the mitochon-
drial membrane (Fig. 18) and found suitability of probe for long-
term mitochondria imaging. Moreover, the authors have also car-
ried out the effect of pH for imaging of mitochondria using the
probe TPE–Xan–In (35) by adjusting intercellular pH between 4.0
and 7.0 and as the pH increases the fluorescence intensity signifi-
cantly increased. Therefore, TPE–Xan–In (35) probe is effective
for tracking the morphology changes of mitochondria due to
changes in intercellular pH.16In recent times, Xinzhe Yang et al [123] have developed the TPE
based luminogens TCPy (36) and TCPyp (37) for imaging mitochon-
dria and secondary AEE for long term tracking of tumour exhibiting
mechanochromism and AIE characteristics. The as-synthesized
pristine solid of TCPy (36) exhibits maximum emission at
512 nm in high Us,o up to 0.90 in solid-state, upon grinding the
peak shift to 526 nm suggesting that the luminogen 36 is highly
sensitive to an external force. Whereas the solid TCPyp (37) in pris-
tine solid emits highly emissive green colour with maximum emis-
sion at 527 nm and Us,o value obtained for this luminogen is 0.52.
Further, upon grinding, the colour changes to red with maximum
at 617 nm, this colour can be returned to its original colour when
fuming with dichloromethane vapour (Fig. 19). Further examina-
tion using single-crystal XRD analysis of solid TCPyp (37) reveals
that the mechanochromic behaviour is due to the deterioration
of intermolecular interactions among hexafluorophosphate anions
present in the crystal under mechanical stimuli, resulting in the
conversion of H-aggregates to J-aggregates. The mitochondria
imaging and cytotoxicity assay of luminongens TCPy (36) and
TCPyp (37) in A549 cancer cells suggest that these AIEgens success-
fully penetrate through cytomembranes, and show good biocom-
patibility in cells (Fig. 19). Moreover, the in vivo imaging studies
of mice suggests that this ionic AIEgen TCPyp (37) can track tumor
for long-term in nude mouse. From these findings, it can be sug-
gested that the luminogen TCPyp (37) has potential applications
in security systems, sensors, and also in the detection of cancer.
Fig. 21. Structure and fluorescence images of probe 39 (10 mM) incubated with
MCF-7 cell along with NIR dye (5 mM). Reproduced with permission from [125].
Copyright 2020 American Chemical Society.
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leads to neurodegenerative lipid storage disorders and its up-
regulation in lysosomes accounted for human breast and colorectal
cancers. It is a good idea to target this enzyme in lysosome in situ
and real-time visualization of Hex using fluorescent imaging,
would be a great tool in cancer diagnosis and drug discovery. ThereFig. 22. Structure of 40. (A & B) Confocal images of 40 (1 mM) and LysoTracker Red (20
wavelength. 40 (405 nm) and Lyso Tracker Red (561 nm). Reproduced with permission
17are very few fluorescent probes for real-time imaging of Hexs with
lysosome-targeting ability, whereas GlcNAc-TPE 38 fluorescent
probe (Fig. 20) found to be sensitive and selective in Hex detection
in live cells [124]. Fabrication of TPE derivative with N-acetyl-beta-
D-glucosaminide group improves the water solubility of the probe
and make the probe to be non emission. Whereas, upon hydrolysis
of probe 38 by Hex produces less water soluble Py-TPE probe 15
which results in aggregation induced emission. Probe 38 showed
specific response to Hex with large stoke shift and good photosta-
bility for in situ visualization of HsHex in live cells. In addition,
colocalization study using LysoTrackerTM Green DND-26 (Fig. 20-
A-H), a commercial lysosome dye suggests that, 38 can specifically
target lysosome and monitor endogenous Hex activity in live
HCT116 cells.
Recently, Yibin Zhang and colleagues [125] showed a fluores-
cent probe 39 in order to visualise the cell-membrane structures
by conjugating TPE with coumarin. The probe 39 was synthesized
by introducing a coumarin organophosphorus yield into 4-[2,2-Bis
(4-methoxyphenyl)-1 phenylethenyl]benzaldehyde. In pure THF,
the synthesized probe 39 shows two absorptions at 300 and
457.5 nm and a single emission at 470 nm, whereas the probe 39
aggregates in the mixture of THF/H2O and changes its emission
behaviour with the increasing water concentration. The probe in
90% water exhibits two emissions with a new emission at
591 nm and a 12 nm red shift in the actual emission at 470 nm
due to the formation of aggregates. The cytotoxicity and photosta-
bility of probe 39 were studied in HeLa cells using standard MTT
assay suggest that cells are viable up to 86% and showed low cyto-
toxicity and good photostability. Further, the authors have carried
out cellular fluorescence imaging of HeLa Cells after 15 min incu-
bating Cell Brite cell membrane NIR dye with probe 39 suggests
that it can solely stain the cell membrane of HeLa cells (Fig. 21).
Moreover, the authors have also utilized probe 39 in fluorescence
imaging of various cell membranes including breast cancer MCF7
cells. These results display that probe 39 specifically stains the cell
membranes.
Yuanjing Cai et al. [126] in 2020 projected an AIEgen for lysoso-
mal tracing, which is based on an acidic pH-stable piperazine-TPE
40 probe. AIEgen PIP-TPE (40) exhibits yellowish-green emission in0 nM) co-stained HeLa cells; (C) A & B merged images; (D) Bright field. Excitation
from [126]. Copyright 2020 The Royal Society of Chemistry.
Fig. 23. Preparation route and quencher-delocalized emission strategy of 42 in living cells for profiling of subcellular GSH. Dual-channel confocal images of HepG2 cells pre-
treated with and without (A) CQ or (B) hydrogen peroxide followed by incubation with 42 for 2 h. (C), (D) Fluorescence distribution of each pixel in (A) and (B) respectively.
Reproduced with permission from [127]. Copyright 2019 WILEY-VCH Verlag GmbH & Co.
Fig. 24. Structure of solids 43–45. Cell imaging of (A) 43 and (B) 44; [(a1, b1) OPEF, (a2, b2) bright-field, (a3, b3) TPEF and (a4, b4) merged images respectively]. Reproduced
with permission from [128]. Copyright 2016 The Royal Society of Chemistry.
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emission, which could be ascribed to the AIE characteristics. Fur-
ther, the probe 40 has explored for selective detection of lysosomes
in cells by incubating HeLa cells under physiological condition with
bio probe PIP-TPE (40) along with commercially available probe
LysoTracker Red (Fig. 22). The imaging in HeLa cells shows blue flu-
orescence with the PIP-TPE (40) probe and red fluorescence with
LysoTracker Red, while the co-staining well merged with a coeffi-
cient of 0.82, which confirms the specificity of PIP-TPE (40)
towards lysosome in live cells. Moreover, the TPE unit in 40 is18hydrophobic, whereas piperazine units are hydrophilic, the incor-
poration of piperazine helps solubility in acidic medium. Further-
more, the cytotoxicity of probe PIP-TPE (40) was also examined
through MTT assay and found that HeLa cells at a higher concen-
tration of 5 lM do not show any cytotoxicity. From these results,
it was found that the probe PIP-TPE (40) has good biocompatibility
and high selectivity towards lysosome with a good signal-to-noise
ratio.
Longyi Zhu et al [127] have employed tetra(4-pyridylphenyl)
ethylene (TPPE) 41-based metal–organic framework (MOF) with
Fig. 25. Structure of hydrogels 46 & 47. Cell viability of 3A6 cells incubated with
10–50 mM of (a) 46 and (b) 47; (c & d) Fluorescent images of 46 (various
concentrations) treated 3A6 cells; (e & f) Fluorescent images of 47 (various
concentrations) treated 3A6 cells. Reproduced with permission from [129]. Copy-
right 2018 The Royal Society of Chemistry.
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form for in situ imaging of subcellular GSH (Fig. 23), which is key in
balancing cellular redox homeostasis. First, Cu(II)-induced electron
transfer phenomenon quenches the fluorescence of 42, however a
green fluorescence is resulted upon endocytosis into cytoplasm
where Cu(II) was contended by GSH to partly delocalize Cu(II) in
AIEgen. There was a complete dissociation of 42 when it is trans-
ported to acidic lysosomes and generates yellow fluorescence
due to binding between Cu(II) and GSH along with TPPE protona-
tion, offering quencher-delocalized emission strategy for monitor-
ing GSH levels. AIE probe 42 showed good biocompatibility with
HEPG2 cells and further investigated the subcellular GSH levels
upon treatment of 42 with HEPG2 cells (Fig. 23). Inhibition of lyso-
some formation was observed when HEPG2 is pre-treated with
Chloroquine (CQ) (Fig. 23A) and reduction of GSH was observed
after treatment with CQ (Fig. 23C). Fig. 23B and 23D suggest the
effective GSH depletion in cytoplasm than lysosome by H2O2.
These outcomes indicate that 42 is suitable for monitoring subcel-
lular GSH levels upon drug treatment.
Ding and colleagues [128] designed a novel strategy for the gen-
eration of D-A-D type structures 43–45 comprising of substituted
triphenyl and TPE units which exhibit AIE properties and studied
their photophysical properties. The synthesized solids 43–45 exhi-
bit dark yellow, yellow, and green colour with a high quantum
yield which is 23.2% for 43, 11.7% for 44, and 10.2% for 45, respec-
tively. Further synthesized solids are explored for solva-
tochromism in various solvents suggesting that all the solids 43–
45 exhibit three absorption peaks, the first one appears at
300 nm, which arises from p-p* transition of triphenylamine or
TPE group, the second one appears at 350 nm and the third one
appears at 400 ~ 425 nm, respectively which attributed due to
ICT. Moreover, the synthesized solids are explored for AIE charac-
teristics and found that the solid 43 in pure acetonitrile solvent
was non-emissive; upon the increase of aqueous fraction the fluo-
rescence intensity improved and gave strong yellow emission at fw
of 90%. Similarly, the solids 44 and 45 emit bright yellow and green
light at fw of 80% and fw of 90%, respectively. The live-cell imaging
and cytotoxicity of luminogens 43–45 were studied in HepG2 and
U2OS cells employing standard MTT assay for 24 h suggesting that
cells are viable up to 80% for solids 43 and 44 and show low toxi-
city with excellent biocompatibility compared to solid 45 (Fig. 24).
In addition, the luminogens 43 and 44 is successfully utilized for
one-photon and two-photon excited fluorescence cell imaging
studies. From these results, it was found that luminogens are good
candidates for bio-imaging with prominent optical properties and
biocompatibility.
Nien-Tzu Chu and co-researchers [129] reported the synthesis
of supramolecular hydrogels TPE-Ser (46) and TPEAsp (47) by sim-
ply conjugating TPE with serine (ser) and aspartic acid (Asp) as a
side chain. The hydrogelators TPE-Ser (46) and TPE-Asp (47) form
hydrogen bonding in aqueous medium and extend their network
to form self-assembly. The synthesized self-assembly was further
tested for hydrogelation formation at various pH conditions and
found that TPE-Ser (46) form stable hydrogel at 2 wt% under a
pH of 7.1, whereas for TPE-Asp (47) requires slight acidic pH of
6.0 for hydrogelation, and these hydrogels exhibit intensive fluo-
rescence emission in gel state. Further, the authors have carried
out biocompatibility of hydrogels through standard MTT assay
using human mesenchymal stem cells 3A6 and found that they
are non-toxic towards 3A6 cells (Fig. 25). Moreover, these hydroge-
lators are further explored for cell imaging applications and found
that these hydrogels 46 and 47 form aggregate in the cytoplasm of
3A6 cells and emit strong blue fluorescence. These results suggest
that hydrogels have good biocompatibility and potential applica-
tions in cell imaging.19A highly emissive conjugated polymer was designed by Sengot-
tuvelu Dineshkumar and co-workers and consists of a donor- p-
acceptor structure, poly(N,N-diphenyl-4-(4-(1,2,2-triphenylvinyl)s
tyryl)aniline), where triphenylamine as electron donor and TPE
as acceptor [130]. In the solid-state, PTPA polymer (48) emits
strong green emission, where as in THF solution it exhibits weak
or non-emissive with small emission intensity at 515 nm. How-
ever, the emission intensity slowly increased when the fw was
increased from 0 to 90% which are attributed to AIE characteristics
of TPE and TPA (48). Afterwards, the mesoporous silica hollow
nanosphere surface was modified with PTPA via non-covalent
bonding to make PTPA loaded MSHNs (49) for cellular imaging.
Further functionalisation also performed with anti-EpCAM (anti-
epithelial cellular adhesion molecule) aptamer via conjugation
with c-glycidoxypropyltrimethoxysilane (GTMS) to yield polymer
Apt-PTPA-MSHNs (51) (Fig. 26). The PTPA (48) polymers, PTPA
MSHNs (49), and Apt-PTPA-MSHNs (51) were evaluated for cyto-
toxicity against different cancer cells through a standard MTT
assay and found that both functionalised polymers are biocompat-
ible towards Huh-7 cells. Moreover, it revealed that aptamer-
conjugated PTPA MSHNs (51) can efficiently internalize the cell
Fig. 26. Structure of PTPA polymer (48). (A) Fluorescent images of cells treated with 49; (B) Fluorescence emitted by Huh-7 cells quantification after treatment with 49.
(concentration of 49 is 100 mg/mL). Reproduced with permission from [130]. Copyright 2019 American Chemical Society.
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bio-imaging applications.
Lei Wang and colleagues [131] synthesised a D-p-A structured
near-IR active AIE fluorophore TPE-PTZ-R (52), which consists of
phenothiazine (PTZ) modified TPE as an electron donor (D) and
malononitrile modified rhodanic as strong electron acceptor (A)
and studied their photophysical properties. The solvatochromism
of as-synthesized fluorophore TPE-PTZ-R (52) was investigated in
different solvents and found that the emission colour changes from
yellow to red in acetonitrile. Further, authors explored the AIE
characteristics of the fluorophore TPE-PTZ-R (52) in THF/water sys-
tem and observed a small red shift from 487 nm to 520 nm with
increasing the water fraction due to the aggregate formation. The
mixture shows a non-emissive property until fw is 70%, while the
fluorescence emission appears above 70% due to the formation of
aggregates and its intensity gradually increased up to fw 99% with
a red shift of the wavelength from 640 nm to 654 nm. The above
results suggest that the fluorophore TPE-PTZ-R (52) exhibit twisted
intramolecular charge transfer (TICT) and AIE features. Moreover,
to impart the water solubility, the fluorophore 52 was encapsu-
lated with Pluronic F-127 to form TPEPTZ-R NPs (53) and were20evaluated for cytotoxicity against HeLa cells and found that the
cells are viable (Fig. 27). The fluorophore TPEPTZ-R NPs (53) emits
red fluorescence with the bioimaging of HeLa cells and are perme-
able to cell membranes to localize the cytoplasm region. These
results suggest that TPEPTZ-R NPs (53) is a promising candidate
for bioimaging applications.
Coordination cages constructed by trinuclear zirconium clusters
possess high stability under different pH conditions, making them
a good candidate for in vitro bio-imaging. Jinqiao Dong and co-
workers [132] have reported two zirconium (IV)-based coordina-
tion cages NUS-100 (54) and NUS-101 (55) (Fig. 28) with AIE char-
acteristics for bio-imaging. HeLa cells imaging in control
experiment using NR-cage displayed weaker imaging than
NUS100-101, highlighting the benefits of AIE molecular rotors in
54 and 55 for live-cell imaging (Fig. 28a-c).
Qing Lin Guan and co-workers [133] have reported bismuth
metal organic framework (Bi-MOF) based Bi-TCBPE 56 (Fig. 29)
sensor with ‘‘turn off” sensing behaviour towards Fe3+ and ‘‘turn
on” towards cysteine. Bioimaging study of luminescent sensor 56
was performed using hUCMSCs and PC-3 cells (Fig. 29). Most cells
are alive with intact morphology with evident blue fluorescence
Fig. 27. Structure of luminogen 52 and fabrication of TPE-PZ-R NPs (53). Confocal images of HeLa cells with (a) co-stained with DAPI; (b) co-stained with NPs 53; (c) merged
image. Reproduced with permission from [131]. Copyright 2018 Elsevier.
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cent dye.
5. TPE based fluorophore for detection and killing of pathogens
Pathogens attack different cells and tissues, and these infectious
particles are responsible for various diseases [134]. Pathogens refer
to a bacterium (Gram-positive or Gram-negative), virus, protozoa,
prion and fungus [135]. Bacterial infection is the prime reason for
many diseases, such as dermatosis, sepsis, pneumonia, inflamma-
tory bowel disease and septic arthritis, which are progressively
increasing across the world [136]. In recent years, multidrug-
resistant (MDR) pathogenic infection possess a serious threat to
mankind [137,138]. In view of this, it is worth to develop a new
and sensitive tool for detecting and identification of pathogens
and to kill bacteria. To overcome these difficulties, many strategies21have been developed for pathogen detection, among them lumino-
gens with AIEgens feature, specifically TPE-based AIEs found to be
a powerful tool for turn-on fluorescent sensing. In this section, we
are listing few recent reports on a promising TPE based derivatives
for identification of drug-resistant bacteria, biosensing, bioimaging
of Gram-positive bacteria and as antibacterial agents.
Different strategies with advanced technologies have been used
to identify microorganism, MALDI-TOF-MS is one among them.
However, these methods suffer from accuracy rate and the fluores-
cent probe is found to be an alternative and promising tool due to
its superior sensitivity. In this direction, Chengcheng Zhou and co-
workers [139] have reported, few AIE-active tetraphenylethylene
derivatives 57–63 (Fig. 30) to identify pathogens with fast response
and superior sensitivity. These derivatives have one positively
charged ammonium group along with different hydrophobic
substituents to reinforce the hydrophobic and electrostatic
Fig. 28. Schematic representation of self-assembly of Zr based metallocages. The HeLa cell confocal microscopy imaging using (A) 54; (B) 55 and (C) NR-cage at (i) 4, (ii) 12,
and (iii) 24 h incubation. Reproduced with permission from [132]. Copyright 2019 WILEY-VCH Verlag GmbH & Co.
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Fig. 29. Structure of 56. (a–c) Packing framework along the layers of Bi-TCBPE (56). Fluorescence microscopy of hUCMSCs and PC-3 cells stained by 56. Reproduced with
permission from [133]. Copyright 2020 Elsevier.
Fig. 30. Structures of 57–63. (A) Schematic representation of TPE-Ars 59, 61 and 63 arrays; (B) Confocal images of pathogens with 59, 61 and 63 (20  106 M). Reproduced
with permission from [139]. Copyright 2018 WILEY-VCH Verlag GmbH & Co.
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Fig. 31. Structure of 64 and antimicrobial function of MSN-PGEDA-CB [7]-TPE (65) nano-assembly. SEM images of E. coli (a, b, and c) and S. aureus (d, e, and f) treated with
nano-assembly with PBS (a, d) and AD (b, e) respectively; in the absence of AD (c, f). Reproduced with permission from [140]. Copyright 2017 American Chemical Society.
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helps to improve the hydrophilicity and flexibility of TPE-ARs. Each
one of the sensor arrays among fourteen competent arrays tends to
pose a different fluorescence response arrangement for different
pathogens, due to unique response of TPE-ARs with the pathogens.
These sensor arrays are 100% effective in identifying drug-resistant
bacteria and they are suitable in multiple pathogens condition.
Detection and developing antimicrobial agents with low cyto-
toxicity is of prime importance in the present situation. Bis-
aminated polymer is known to decrease the cytotoxicity of poly-
mers. Qiaoying Li and co-workers [140] have constructed a novel
LBL supramolecular nanoassembly of MSN-PGEDA-CB[7]-TPE (65)
using TPE-based tetracarboxylic acid (64) and used these assem-
blies for the detection of bacteria and as antibacterial agents
(Fig. 31). The negative surface of bacteria firmly binds to PGEDA
positive surface to form a LBL nano-assembly and losses the AIE
activity of TPE, resulting in fluorescence quench. Moreover, the
addition of adamantaneamine forms a stable complex by the liber-
ation of PGEDA, which results in the release of AMO that enhances
the antibacterial property of nano-assembly. Different experiments24demonstrated that the ability to kill bacteria is controlled by
supramolecular dis-assembly process. The SEM images are also
suggesting that the antibacterial property of nano-assembly is
due to the distortion of the bacterial interacting membrane with
disassociated MSN-PGEDA-CB[7]-TPE (65). The cytotoxicity of
nano-assembly was found to be low in CCK-8 assay.
Viraj G. Naik et al [141] synthesised-TPE based AIE probe for the
imaging of Gram-positive bacteria using mono-sulfonate (66) and
di-sulfonate (67) functionalized TPE with long alkoxy chains
(Fig. 32). The mechanism explained here is that the positive NH3+
group of lipoteichoic acid (LTA) present in the surface of Gram-
positive bacteria interacts with SO3 group in the probe and turns
on the fluorescence of the AIE probe. The Gram-positive bacteria
were detected selectively by different fluorimetric studies,
whereas the negligible increase in fluorescence intensity was
observed for the Gram-negative bacteria in aqueous solution.
Moreover, good aqueous solubility and negligible fluorescence
make di-sulfonate functionalized TPE probe more suitable for
Gram-positive bacterial imaging, helping the imaging process
easier and providing more accuracy in quantification without sig-
Fig. 32. Structures of 66 and 67. (A–E) Phase contrast; Fluorescence images of (F) S. aureus; (G) B. subtilis; (H) P. aeruginosa; (I) E. Coli; (J)M. smegmatiswith probe 67 (30 mM).
Reproduced with permission from [141]. Copyright 2020 The Royal Society of Chemistry.
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has antibacterial property against S. aureus and the growth kinetics
of di-sulfonate probe well matched with kanamycin antibacterial
agent.
Biofilm sample detection can be done by various laboratory-
based techniques, most of them lack in signal amplification, affect-
ing the efficiency of imaging process. To find an effective solution
for this problem, Junxin Aw et al. [142] reported a covalently linked
cephalosporin structure (class C AmpCBla enzyme sensitive repor-
ter molecule) with TPE moiety (68 and 69) which helps in detec-
tion of drug-resistant pathogens in biofilms. AIE characteristics of
TPE make this molecule to be a good candidate for biosensing
and bioimaging (Fig. 33), unlike the other fluorophores quench
the fluorescence in the aggregation. Achievement of selective
recognition towards Class C Bla is attributed to the bulky methoxy-
imino group on cephalosporin ring. The selective localization of
fluorescent labelling greatly helps in the monitoring of biofilm for-
mation, providing valuable information for the better treatment
against bacterial infections.
Fang Hu and colleagues [143] developed TPEPy-D-Ala (70) as a
dual-functional probe with D-alanine and a photosensitizer based
bacteria-metabolizable for turn-on fluorescence imaging of hidden
intracellular bacteria and photodynamic ablation in situ. The incor-
poration of probe into bacterial peptidoglycan improves fluores-
cent signals to provide better visualization of the intracellular
bacteria. On the other hand, ligations of TPEPy-D-Ala (70) to pepti-
doglycan effectively can ablate the labelled intracellular bacteria
in situ, with MIC of 20 ± 0.5 lg/mL (Fig. 34). This low MIC value
suggests that the TPEPy-D-Ala (70) is more efficient than the stan-
dard antibiotic, vancomycin.256. TPE-based probes for cancer diagnosis
Currently, cancer is a serious threat to humans and causes sev-
ere mortalities worldwide. Among them, many reports pointing
that the top threat in the world continues to be breast cancer
[144]. In human cancer treatment, chemotherapy is a commonly
used method and found to be an effective therapy, and most of
the chemotherapeutics are based on small molecules [145,146].
These therapeutics based on small molecules exhibit several disad-
vantages in clinical trials due to their low solubility, less bioavail-
ability and poor cancer specificity that restrict their application in
cancer therapy. Nanomedicine is found to be a great alternative to
small molecule therapeutics for cancer treatment [147]. Compared
with conventional hydrophobic organic molecule-based drugs,
drug-loaded nanocarriers possess better stability and specificity
in biological conditions. Further, researchers continued their effort
to provide better alternatives to overcome the drawbacks of
chemotherapy, mainly by early diagnosis, therapy before cancer
metastasis and imaging-guided drug delivery.
The advancement of fluorescence bioprobes with AIEgens
serves as an excellent agent to monitor biological process [148]
and disease theranostics [149], whereas commonly used nanopar-
ticles fluorogenic experience low quantum yields due to their ACQ
property. Till date only few research groups have focused on devel-
oping redox-responsive AIE bioconjugate NPs for targeted cancer
therapy. Ling Yang and co-workers [150] are among them who
have designed and synthesized redox-responsive AIE bioconjugate
nanoparticles (72) consisting of disulfide bond to target the sup-
pression of cancer cells (Fig. 35). The nanoparticle bioprobe con-
tains chitosan polymer chain linked to a greater number of TPE
Fig. 33. Structures of 68 and 69. Confocal imaging of different bacterial strains with 20 lM of 68 in 0.1 M PBS. Reproduced with permission from [142]. Copyright 2020 The
Royal Society of Chemistry.
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ological condition, these nanoparticle bioprobes exhibit excellent
water dispersibility and dispersive fluorescent emission. The disul-
fide bond is easily cleavable and consequently losses the carboxylic
group which results in the aggregation of TPE-chitosan. This aggre-
gation increases the retention of nanoparticle intracellularly and
elevates the emission brightness. The aggregation-enhanced reten-
tion process helps to trace the biological fate of the cancer cells.
Flow cytometry experiment suggests that TCSC NPs (72) induce
apoptosis of HeLa cells and result in their necrosis. It is clear that
these nanoparticle bioprobes can be employed for selective inhibi-
tion of cancer cells and for targeted cancer cell imaging reinforce-
ment. Even though it is a superior agent to monitor the biological
process, its blue-emitting fluorescent system restricts in vivo imag-
ing, which can be overcome by developing red-emitting AIE
bioconjugates.
Tianyu Li and co-workers [151] developed selenium-
comprising of AIEgen to support the combined treatment of26chemotherapy and radiotherapy to combat cancer. Since dise-
lenide bonds are sensitive to c-radiation, authors have included
TPE into the diselenide system to achieve AIE property. Upon
gamma irradiation, diselenide bonds break to seleninic acid,
inducing a high level of ROS generation and subsequent cytotox-
icity against cancer cells. Both compounds 73 and 74 showed
anticancer activities against breast and lung cancer cells under
c-radiation explored by CCK-8 assay. Breast cancer cells itself
showed a mild fluorescence, but there is an increased fluores-
cence intensity upon irradiation of c-rays suggesting the produc-
tion of ROS in water, which is confirmed by DCFH-DA assay and
CLSM inspection (Fig. 36). Further, increased fluorescence inten-
sity of the cells treated with compound 73 is attributed to the
selenic acid formation upon c-radiation and the flow cytometry
analysis results demonstrate that the c-radiation promoted the
high ROS level in cancer cells. These results showed that the com-
bination therapy of selenium-based nanomedicine may advance
the cancer treatment efficiency.
Fig. 34. Structure of 70. (A) Schematic illustration of 70 fluorescence. Confocal
image of (A) MRSA and (B) E. coli (C) cells treated with 70 for 20 min. Reproduced
with permission from [143]. Copyright 2019 WILEY-VCH Verlag GmbH & Co.
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orthogonal reaction with high selectivity. The reaction performed
in a biological system without harming the normal physiological
process with reliability and selectivity called bio-orthogonal reac-
tion. Pengfei Zhang et al. [152] have employed this strategy to
develop polyyne-bridged AIEgens, 2TPE-4E (75) and embedded
into DBCO-PEG-lipids to create AIE dots (76) to target cancer via
complementing metabolic engineering and bio-orthogonal chemi-
cal reaction. 2TPE-4E (75) consists of two N, N-diethyl substituted
TPE derivatives on both the ends of polyyne having D-p-A struc-
ture. This polyyne bridge increases the conjugation, resulting in
the bathochromic shift and restricts the emission quenching. The
examination of cell labelling and bio-orthogonal efficiency of AIE
dots were found to be fruitful in MCF-7 cancer cells in vitro
(Fig. 37). Authors have also developed an in vivo metabolic label-
ling approach for delivering AIE dots specifically to tumor and tar-
geting imaging. Bio-orthogonal chemical reaction considered as an
important technique for bioprobes to use in biological substrate
labelling in living system.
Ziyu Wang and co-authors [153] reported self-illuminating
drug carriers using AIE-active probes by altering electron donor
in the donor–acceptor (D-A) assembly for antitumor treatment
structures. By varying the electron donor groups, the fluorescence
behaviour of polymers 77, 78 and 79 could interconvert between27AIE and ACQ. Apart from its self-illuminating ability, these polymer
dots along with paclitaxel (an anticancer drug) had a better bio-
compatibility and in vivo anticancer property compared to Taxol
(Fig. 38). Authors have provided an effective method for producing
multicoloured AIEgen drug carriers.7. TPE-based bio probes for photodynamic therapy
Photodynamic therapy (PDT) is employed to kill cells under vis-
ible light irradiation based on photosensitizers (PSs) which can
produce ROS [154,155]. So far, various photosensitizers including
porphyrin, BODIPY, nanocrystals, and many more have been
reported in the literature with near-infrared (NIR) emission
[156–159]. However, most of the fluorophores are hydrophobic
in nature quenched from ACQ effect, leading to a decrease in gen-
eration of ROS and the fluorescence intensity greatly reduced in the
aggregated state due to discotic structures [160,161]. Thus, the
development of AIE PSs has intensified fluorescence by absorption
and emission and negligible toxicity as well as good biocompatibil-
ity in the (nano) aggregated form is highly promising.
Wenbo Wu and co-workers [162] designed and synthesized
D-A’-p-A type AIE photosensitizers 80–85 (AIE PSs) in which meth-
oxy substituted TPE exerts electron-donating property and dicya-
novinyl (DC) group as an electron acceptor and benzene as p
spacer between D-A substituents (Donor-Acceptor) and benzothia-
zole as auxiliary acceptor. The benzothiazole group in D-A’-p-A
structure serves as p spacer for the facile separation of HOMO
and LUMO energy gap between S1 and T1 state and favours ROS
generation. Due to poor solubility of AIE PSs (80–85) in water,
AIE PS were encapsulated with DSPE-PEG2000 to form AIE PS NPs
80–85. The synthesized AIE PS NPs 80–85 were explored for 1O2
generation and found that in bright far-red (FR) and NIR emission
AIE PS NPs 84 and 85were effective for 1O2 generation and improv-
ing absorption (Fig. 39). Subsequently, both AIE PS NPs 84 & 85
show high level of ROS production against MDA-MB-231 cells with
dichlorofluoresceindiacetate (DCFDA) as ROS sensor under white
light irradiation (Fig. 39). Further, synthesized AIE PS NPs 84 and
85 showed low IC50 (<1.0 lg/mL) confirming that AIE PS NPs dis-
play low cytotoxicity and generate more 1O2 species to inhibit
MDA-MB-231 cells under PDT treatment. Thus, AIE PS NPs 84
and 85 are promising candidates for image-guided PDT and open
new opportunities in clinical applications.
Jianjiao Chen et al. [163] synthesised dimerized TPE derivative
BTPE (86) as photosensitizer with AIE properties for PDT. The
biphenyl TPE dimer BTPE (86) was synthesized by Suzuki-
coupling reaction which was encapsulated with DSPE-PEG-2000 to
form BTPE NPs (86) by nano-precipitation method. The
as-synthesized BTPE NPs (86) are further investigated for AIE char-
acteristics and found that with enhanced water fraction in THF/wa-
ter, the fluorescence intensity gradually increased due to the
accumulation of aggregates. From the TEM image, it was found that
the self-assembled BTPE NPs (86) display a mean diameter of
approximately 70 nm. The authors have further explored BTPE
NPs (86) for singlet oxygen generation ability under visible-light
illumination using SOSG as a singlet oxygen sensor and confirm
that BTPE NPs (86) generate more 1O2 than that of monomer TPE
ones which are crucial for PDT. Subsequently, authors have
explored the generation of ROS using DCF-DA as ROS sensor and
found that 86 is capable of generating ROS in a highly efficient
manner which were observed under CSLM (Fig. 40). To further
evaluate phototoxicity of BTPE NPs (86) standard MTT assay were
carried out against HeLa cells and found that NPs show IC50 of
8.4 lg mL1 which is better than monomer TPE NPs. An in vivo
experiment suggests that 86 under light irradiation can suppress
tumor proliferation. From these results, it was found that BTPE
Fig. 35. Structures of 71 and 72. (A–D) Confocal images of various cells (FIB, HeLa, HepG2, MCF-7) stained by NPs 72 (0.1 mg mL1) and Mito Tracker Red CMSRos for
localization of 72. Blue first column for 72 particles; Red second column for mitochondria; Third column is merged fluorescent channels; Fourth column corresponds to bright
field images. Reproduced with permission from [150]. Copyright 2019 The Royal Society of Chemistry.
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Fig. 36. Structure of polymers 73 and 74. (A) CLSM pictures exhibiting both AIE fluorescence and ROS levels; (B-C) Anticancer activity of 73 & 74 under gamma-radiation
against MDA-MB-231 cells. Reproduced with permission from [151]. Copyright 2020 American Chemical Society.
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compatibility as superior candidates for in vivo applications under
PDT effect.
C. Parthiban and co-researchers [164] synthesised a TPE-based
visible-light triggered fluorescent nanoparticles (TPE-pHP-Cbl
NPs) (87) using p-hydroxy phenacyl chlorambucil (pHP-Cbl) for
chemo-photodynamic therapy (Fig. 41). The as-synthesized tetra-
phenylene substituted-p-hydroxyphenacyl-chlorambucil (TPE-
pHP-Cbl) was subsequently synthesized to form TPE-pHP-Cbl NPs
(87) with mean diameter of ~8 nm by reprecipitation method.
The in vitro study was performed to monitor drug release by 87
in HeLa cells. A yellow fluorescence appeared in the HeLa cells after
incubation of 87 for 8 h owing to cellular uptake of 87 (Fig. 41b).
Light green fluorescence (Fig. 41c) appeared after irradiation of
light for 3 min suggesting the partial decomposition of 87 and
complete fluorescence colour change was noticed after 5 min of
light irradiation, revealing the release of drug by 87 inside the cells
(Fig. 41d). These results suggest that 87 is a promising fluorescent
nanoparticle for real time cellular imaging with synergistic effect
(combination therapy). The high fluorescent intensity of 87 is
attributed to its AIE characteristics. Exposure of 87 to light simul-
taneously generate singlet oxygen and stimulated drug release.
Besides, released photoproduct can enhance production of singlet
oxygen. Further, the cytotoxicity studies were carried out for
TPE-pHP-Cbl NPs (87) by standard MTT assay against HeLa cells
and normal cell line (HaCaT cell) by irradiating visible light, and
cells are found to be viable and nontoxic which are attributed
due to PDT and chemotherapeutic effect.
Parthiban and co-researchers [165] have also reported TPE-
based light-responsive fluorescent organic nanoparticles (TPE29(Cbl)4 (88) for PDT using aggregation-induced-emission process.
TPE(Cbl)4 conjugate is synthesized by AlCl3 catalysed acylation of
TPE using bromoacetyl bromide followed by the reaction with
chlorambucil (Cbl). Different experimental results disclosed that
TPE(Cbl)4 NPs are spherical with diameter of approximately
42 nm. Hence, these drug-loaded nanoparticles can efficiently pen-
etrate into tumor cells and due to the decreased lymphatic drai-
nage, they are retained in the tumor bed. This process is called
enhanced permeability and retention effect. The drug release capa-
bility of TPE(Cbl)4 NPs with visible-light exposure was monitored
using HPLC and fluorescence and the obtained data suggested that
96% of the drug release was achieved after 25 min of irradiation.
The light and dark experiments revealed that the light is necessary
to release drug from the NPs (Fig. 42). In addition, the high-
resolution mass spectrometry analysis points that the release of
4 equivalent of the antitumor compound (cbl) from the nanosys-
tem is sequential rather simultaneous in their aggregated state.
The cytotoxicity of TPE(Cbl)4 NPs verified by MTT assay on HeLa
cell lines exhibit promising antitumor property owing to the drug
release and PDT activity.
Sijia Gao et al. [166] have revealed that organoplatinum (II)
metallacycle possesses AIE property and acts as a photosensitizer.
It self-assembles with tobacco mosaic virus coat protein, which is
decorated with a trans-acting activator of transduction (TAT) pep-
tide through electrostatic interactions 89–93 (Fig. 43). The transi-
tion element platinum helps ISC from a singlet to triplet state to
mediate ROS production and this assembly exhibits strong
membrane-intercalating ability due to self-assembly of negatively
charged protein moiety with the positively charged organoplat-
inum (II) metallacycle. This ROS generation from the photosensi-
Fig. 37. Structures of 75 and DBCO-AIE dots (76). (A) Standardization of Ac4ManNAz and CLSM images of Ac4ManNAz treated (3 days) MCF-7 cells with further incubation
with 76 (30 min); (B) in vitro optimization of Ac4ManNAz incubation time for metabolic labelling of the MCF-7 cells. Reproduced with permission from [152]. Copyright 2019
WILEY-VCH Verlag GmbH & Co.
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potentially enhance the photodynamic inactivation (PDI) efficiency
against bacteria. The PDI efficiency is found to be much better and
selective against Gram-negative bacteria. The morphology exami-
nation by SEM and TEM after irradiation reveal that the possible
antibacterial mechanism is due to the membrane lysis by ROS. This
membrane-intercalation-enhanced PDI behaviour of this assembly
can be selectively used as a promising candidate for PDI in Gram-
negative bacteria elimination.
WenboWu and co-workers [167] have reported new AIE photo-
sensitizers of TBT (94) having aggregation-induced NIR emission
centred at 810 nm and under white light irradiation showed high
singlet oxygen generation efficiency. Further substitution of two
long-chain branched alkyl groups to TBT avoids the strong interac-
tions in the solid state for TBTC8 (95) and NPs also show band at30810 nm with good singlet oxygen generation efficiency. The effect
of PDT was examined in 4T1 cancer cell in vitro incubated with
TBTC8 NPs which showed excellent cell imaging ability (Fig. 44).
Authors have further explored the capability of TBTC8 NPs in
in vivo tumor therapy. These results indicate better in vivo tumor
imaging function of TBTC8 NPs.
AIEgens in aggregated state with efficient emission and ROS
production are superior photosensitizers for fluorescence guided
photodynamic therapy (FL-PDT) than traditional photosensitizers
used in PDT. The tumors demonstrate high viability in hypoxic con-
dition due to enhanced levels of H2O2 and lipid droplet (LD) accu-
mulation. Consequently, development of LD-targeted, H2O2
activatable AIE-active photosensitizer for FL-PDT is of great inter-
est. AIE active amphiphilic TPECNPB probe 96 (Fig. 45) is fabricated
with positively charged pyridinium pendent with boronate ester
Fig. 38. Structure of polymers 77–79. (A) Cellular imaging of PTX-loaded 77 dots and (B) 78 dots in MCF-7 cells. Reproduced with permission from [153]. Copyright 2020
American Chemical Society.
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static attraction [168]. Absorption and PL spectra of probe
TPECNPB 96 revealed the large stoke shift (175 nm) and exhibited
excellent photo stability. Probe 96 can accumulate selectively in LD
and undergoes activation by endogenous H2O2 for light-up
bioimaging in live MCF-7 cells (Fig. 45). PDT induced cell apoptosis
of MCF-7 cells was observed after treating with H2O2-activated
TPECNPB. This probe would be a great addition for both real-
time monitoring and PDT of tumors.8. TPE-based probes for drug and gene delivery
Tumor therapy and diagnostics using smart nanostructures pos-
sess various advantages over biomolecules and small molecule
drugs [169]. Delivering drugs specifically to tumors is the basic
need in cancer therapy and the nanoparticles have this capability
via EPR effect, that reduces the drug side effects [170,171].
Recently, great interest has been shown to multifunctional nano-
carriers due to its progressive effects on cancer therapy [172].
The integration of fluorescent tracing molecule and drugs with
theranostic nanoparticles have shown improved efficacy in cancer
treatment [173]. The drug-releasing ability of carriers would
greatly influence the efficacy of drug that help for developing a
drug delivery strategy. As it is known, the fluorescence emission
intensity diminishes for most of the organic luminophores due to
ACQ effect, which significantly impedes the bioimaging effect as31well [174]. To avoid these undesired ACQ effects, AIE fluorophores
have been successfully employed for cancer treatment and
imaging-guided drug delivery [175]. The advantage of the AIE
nanoaggregates is that they can sustain in the live cells for longer
time without losing fluorescence intensity for long term tracing of
the cells [176]. Still, it is a demanding task to co-ordinate the inter-
action of the nano-carriers with biological system for cancer ther-
apy in vivo. Therefore, designing a suitable nano-carrier for
controllable drug transport and specific delivery targeting the
tumor sites demands a lot of attention from researchers.
Fang Hu and co-workers [177] have synthesized dual-prodrug
by the reaction of Mitomycin C (MMC) and TPE substituted with
mono vinyl pyridine (TPEPY) photosensitizer (PS) via a disulfide
link that can activate the chemo-prodrug TPEPY-S-MMC (98).
Aggregated state of TPEPY has high ROS generation efficiency but
TPEPY-S-MMC (98) has quinine component that exerts a quench-
ing effect in MMC moiety, affecting the ROS generation. 4T1, HeLa
cancer cells and 293T normal cells were used to assess the cytotox-
icity and for living cell imaging of TPEPY-S-MMC (Fig. 46). These
images suggest that the intracellular GSH concentration is highly
responsible for activation of TPEPY-S-MMC (98) and showed good
selectivity to cancer cells over normal cells. Upon white light irra-
diation, TPEPY-S-MMC (98) and DCF-DA (20,70-dichlorofluorescein
diacetate) treated 4T1 and HeLa cells were highly emissive, while
poor green fluorescence was displayed for cells pre-treated with
buthionine sulfoximine (BSO, GSH inhibitor) confirming that the
intracellular activation was not undertaken by GSH. More interest-
Fig. 39. Structures of AIE PS (80–85). (A) scheme of AIE PS NPs (80–85); (B) Confocal images of 80–85 NPs incubated MDA-MB-231 cells with 5 mg/mL concentration; (C) Live/
dead staining of 82–85 NPs treated MDA-MB-231 cells. Reproduced with permission from [162]. Copyright 2017 The Royal Society of Chemistry.
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and HeLa cells does not show neither red fluorescence from PS nor
green fluorescence from emissive DCF due to non-cleavable C–C
linker. The C.I analysis confirms that the combined delivery of
MMC and TPEPY-SH as a prodrug in TPEPY-S-MMC (98) results in
an increased tumor killing ability with minimal damage to normal
tissues, restoring of red fluorescence indicates the drug releasing
from the TPEPY-SH.
Tian-Tian Wang and co-workers [178] prepared doxorubicin-
loaded polyethylene glycol-block-peptide (FFKY)-block-tetraphe
nylethylene (PEG-Pep-TPE/DOX) NP’s (100) and D-peptide to32dynamically detect the drug release as shown in Fig. 47. FRET
imaging being useful to study the release of drug molecules from
nanoparticle; authors have attempted three different methods
for quantitative detection of the release and circulation of the
nanomedicine in A549 cells. All the above-mentioned analyses
suggest that under in vitro laboratory condition, peptide NP’s
100 were highly sensitive to recognize drug release in cells.
MTT assays of free DOX, PEG-Pep-TPE NPs and 100 against
A549 cells suggest that self-assembled peptide with doxorubicin
is favoured for the inhibition of cancer cell proliferation with
undesired side effects.
Fig. 40. Structure of 86. (a) Internalization of 86 NPs in HeLa cells; (b) ROS generation of 86 NPs with DCF-DA; (c) MTT assay of TPE NPs on HeLa cells; (d) MTT assay of 86 NPs
on HeLa cells. Reproduced with permission from [163]. Copyright 2020 Centre National de la Recherche Scientifique (CNRS) and The Royal Society of Chemistry.
Fig. 41. Structure of 87. (a) Confocal bright-field image of HeLa cells and (b-d) upon light irradiation at various time intervals. Reproduced with permission from [164].
Copyright 2018 American Chemical Society.
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Fig. 42. Structure of 88 and Schematic illustration of fluorescent nanoparticles 88 for chemo-photodynamic therapy under visible light. Formation of reactive oxygen using 88
by HeLa cell stained with DCFDA (a) bright field and (b) 0, (c) 10, and (d) 25 min of light irradiation. Reproduced with permission from [165]. Copyright 2019 American
Chemical Society.
Fig. 43. Representing the self-assembly of metallacycle 89 and protein 90; Mechanism of action of 91; Self-assembly of metallacycle 89 and protein 92. (A–H) SEM images of
E. coli cells; (I and J) TEM images of E. coli; K and L are enlarged images. Reproduced with permission from [166]. Copyright (copyright year) National Academy of Sciences.
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Fig. 44. Structure of photosensitizers 94–95. Confocal fluorescent images of 4T1 cancer cells after incubated with (A) 95 NPs or (B) 94 NPs for 12 h. ROS generation with (C) 95
NPs or (D) 94 NPs loaded 4T1 cells. (E) Cell viability of 95 treated 4T1 cells. Reproduced with permission from [167]. Copyright 2019 WILEY-VCH Verlag GmbH & Co.
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polymers (101 and 102) via Suzuki coupling polymerization reac-
tion with colour tunable activity by changing their intramolecular
FRET pairs. These conjugated polymers have been used to carry
drugs for self-indicated therapy for cancer (Fig. 48). The studies
reveal that exact location can be detected when using these the
two polymers as drug carriers with a model drug paclitaxel (PTX)
due to their different AIE characteristics. The biocompatibility of
101 and 102 were assessed on LO2 cells by MTT assay and both
the CPNs showed low cytotoxicity and preferable biocompatibility.
The in vitro anticancer ability was analysed for PTX loaded CPNs
and PTX on HeLa and A549 cancer cell lines, where the PTX loaded
CPNs show sustained release property with slightly lowered cyto-
toxicity on both Hela and A549 cells.
Chi Zhang and co-researchers [180] integrated a chimeric pep-
tide comprised doxorubicin (DOX) to overcome tumor MDR
(Fig. 49). This transformable chimeric peptide forms packed cell
networks via morphological changes for cell encapsulation, con-
trolling drug efflux and reversing tumor MDR. The chimeric pep-
tide CTGP (103) (C16-K(TPE)-GGGH-GFLGK-PEG8) initially formed
nano micelle assemblies to create a peptide-based nanosystem
DOX (CTGP@DOX (104) by encapsulating the anticancer agent for
drug delivery. The release of the drug by the addition of cathepsin
B is controlled by the disassociation of CTGP@DOX (104), which is
further confirmed by fluorescence spectroscopic kinetic studies.
Further confocal studies revealed that the weak fluorescence from
CTGP and DOX are due to FRET and ACQ effect, whereas
CTGP@DOX (104) exhibit high intensities of blue and red emission
after incubating with cathepsin B. Different biological experiments35have showed that CTGP@DOX (104) could be separated by cathep-
sin B-overexpressed MCF-7S (drug-sensitive) and MCF-7R (drug-
resistant) cells (Fig. 49). Further rearrangements to nanofibers on
the cell membranes restrict the DOX efflux. The CTGP@DOX
(104) showed a long-term blood circulation than free DOX, high
anti-MDR capacity and better anticancer effects in in vivo test.
Yixia Qian et al. [181] have attempted for accurate tumor tar-
geting therapy, in vivo imaging and apoptosis monitoring by an
advanced micellar delivery system (STD-NM) (106). This STD-NM
system were functionalised with peptides (ST and TD) and an
AIE. The purpose of AIE molecule TPE (105) is to show the ’switch
on’ fluorescence during apoptosis. ST in the peptide is constituted
of pH-controlled targeting peptide STP (sequence:
SKDEEWHKNNFPLSPG) and TD is a tumor acidity-activated pep-
tide, which is essential for the nanocarrier to keep it in good func-
tionality under normal conditions. Both the peptides enhance the
cell permeability and cell penetration of the activated STD-NM
(106). In vivo imaging assays of NIR fluorescent dye 1,1-dioctade
cyl-3,3,3,3-tetramethylindotricarbocyanine iodide encapsulated
STD-NM (106) on HT-29 xenografted mouse model suggests that
the nanocarrier STD-NM (106) specifically targets and penetrate
to deeper tumour site and sense the tumor cell (Fig. 50). In vivo
therapeutic results indicate that the peptide performs better in
combined form than the single function of ST and TD. Furthermore,
authors have investigated therapeutic effects on genetic level using
RNA-sequencing technique and the supervised Gene Ontology
(GO) experiments.
Xiangdong Xue and colleagues [182] have attempted to gener-
ate a self-indicating drug delivery system (SIDDS), having ability
Fig. 45. Structures of fluorescent probe 96 & 97. Confocal laser scanning microscopy (CLSM) images of MCF-7 cells incubated with 96 with or without lipopolysaccharide.
Reproduced with permission from [168]. Copyright 2020 WILEY-VCH Verlag GmbH & Co.
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(105) assembled to self-luminescent nanoparticles to show AIE
which can be easily tracked inside the cell. The formed TPE NPs
(107) have superior activity compared to conventional drug deliv-
ery system without showing ACQ effect and exhibited low cytotox-
icity and good biocompatibility. Further, TPE NPs (107), free DOX,
and TD NPs (108) were incubated with MCF-7 cells to examine at
sub-cellular level (Fig. 51). The study reveals that TPE NPs were
traceable in the cytoplasm but not in the nucleus, that the fluores-
cence of TPE (105) was weaker than TPE NPs (107) due TD NPs
(108) quenching and co-localization of DOX suggests some of
DOX and TPE still aggregates as TD NPs (108) when they are taken
into cells and further, the sub-cellular level of TPE NPs (107) and
DOX can be determined when they come in contact together and
shows high FL intensity. This suggests SIDDS could be a promising
drug delivery system, which determined the subcellular location of
the delivery system along with the improved therapeutic effect.
Qing-Lan Li and coresearchers [183] have constructed newmul-
tifunctional drug delivery system by modifying per-6-thio-b-36cyclodextrin (CD) entities on copper sulfide (CuS) through ligand
exchange to form CD-CuS nanoparticles. In further, the CD-CuS
nanoparticles attached onto benzimidazole-grafted fluorescent
TPE-functionalized mesoporous silica nanoparticles 110 (FMSN)
to integrate FMSN@CuS, a pH stimuli-responsive controlled drug
delivery system (CDDS) (Fig. 52). Anticancer drug DOX moieties
are loaded into FMSN@CuS, eventually CD-CuS at physiological
pH (7.4) displayed zero prerelease of anticancer drug DOX and also
on-demand DOX release at an acidic pH attributed to the pH-
responsive gate-opening of CD-CuS under acidic pH. In further,
DOX-loaded FMSN@CuS 112 enhances the fluorescence intensity
upon release of drug, which is useful phenomenon to track the
intracellular drug release event depending on the variation of
luminescence intensity. Interestingly, DOX-loaded FMSN@CuS
demonstrated a very good synergistic effect upon 808 nm laser
irradiation against cancer cell line SGC-7901 via enhanced
chemotherapy and photothermal therapy (Fig. 52A & B).
Development of safe and efficient vectors is the basic criteria for
successful gene therapy [184], and the major challenges for
Fig. 46. Structures of 98 and 99. (A) Tumor volume measurement after intratumoral administration with PBS, 99 NPs and 98 NPs along with or without white light
irradiation; (B) Body weight change for all mice during the treatment period; (C) H&E staining for tumor at day 5 after treatments. Reproduced with permission from [177].
Copyright 2017 Elsevier.
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and subsequent nucleic acids unpacking in cytosol. To address
these issues, Youyong Yuan and coworkers [185] have developed
light controlled and ROS-responsive polymeric gene delivery vec-
tor (Fig. 53) comprising of TPE based AIE photosensitizers (PSs)
coupled with oligoethylenimine (OEI) (800 Da) using aminoacry-
late (AA) linker 113 (Fig. 53). Low molecular weight OEIs are
advantageous as arms over polyethyleneimine (PEI) due to its37effective DNA binding ability and lower toxicity. The aqueous sol-
ubility of the polymer is drastically improved upon grafting with
PEG and helps to self-assemble into nanoparticles in water media.
The prepared polymer can easily bind to DNA via electrostatic
interactions 114 (Fig. 53). The generated ROS upon light irradiation
helps vectors to escape through membranes disruption from endo/
lysosomes. Parallelly the polymer breaks down to smaller sized
components by ROS, leading to unpacking of DNA. This method
Fig. 47. Structure of PEG-Pep-TPE/DOX (100) and Schematic representation of drug release behaviour of the self-assembled PEG-Pep-TPE/DOX (100) nanoparticles. (A) FRET
intensities analysis of the A549 cells with NPs 100 for 3 h; (B) Plot of average FRET intensity versus time of A549 cells with NPs 100 for 3 h; (C) in vitro cytotoxicity of free DOX,
NPs 100 and PEG-PepTPE NPs against the A549 cells after 72 h; (D) Confocal images of pre-treated cells for 12 h with PBS control, PEG-PepTPE NPs, free DOX and NPs 100.
Reproduced with permission from [178]. Copyright 2020 The Royal Society of Chemistry.
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Fig. 48. Structures of 101 and 102 and representation of the self-indicated tumor treatment using AIE-active CPNs as drug carriers. (A) Cellular imaging of PTX-loaded CPNs-
101 and (B) CPNs-102 in HeLa and A549 cells [green signal from PTX-loaded CPNs-101 and red signal from PTX-loaded CPNs-102]. Reproduced with permission from [179].
Copyright 2020 The Royal Society of Chemistry.
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Fig. 49. Structures of CTGP (103) and CTGP@DOX (104). Suggested mechanisms of i) peptide-DOX self-assembly, ii) cathepsin B-instructed micelles disassociation with DOX
release and fluorescence recovery, and iii) CTGP@DOX nanofiber reassembly; CLSM images of (A1–A4) MCF-7S cells; (B1–B4) MCF-7R cells and (C1–C4) MCF-7R cells pre-
treated with P-gp inhibitor after incubation with 104; (D1, E1) Flow cytometry analysis of MCF-7S and MCF-7R cells after treated with free DOX and 104; (D2, E2) The
fluorescence intensity of intracellular DOX assessed by flow cytometry; (D3, E3) DOX retention efficiency for MCF-7S and MCF-7R cells. Reproduced with permission from
[180]. Copyright 2018 WILEY-VCH Verlag GmbH & Co.
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Fig. 50. Structure of 105; (A) Flow cytometric analyses of the internalization by HUVEC cells at pH 6.5 and (B) by macrophages cells at pH 6.5 of STD-NMdrug (106), ST-NMdrug,
Free DOX respectively; (C) Flow cytometric analyses of the internalization of STD-NMdrug by macrophages cells at different conditions; (D) CLSM images of 106 toward HUVEC
cells at various conditions; (E) The fluorescence intensity of TPE and DOX, respectively. Reproduced with permission from [181]. Copyright 2019 Elsevier.
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unpacking, which are key events for gene delivery. The intracellu-
lar trafficking profile (Fig. 53A–E) of ROS-sensitive nanoparticles
(S-NPs)/DNA complexes confirms that the complexes are
entrapped in endo/lysosomes (Fig. 53A3 & A4), Fig. 53B1-4 indi-
cates light-induced intracellular DNA release after polymer break-
down (Fig. 53D2).41Nanoscale coordination polymers (NCPs) are organic–inorganic
hybrid materials constructed from the metal ion and polydentate
bridging organic core, represent a key entity for future nanomate-
rial application in nanomedicine. A new TPE immobilized
zirconium-containing nanoscale coordination polymer 115 (TPE-
NCPs) [186] with improved AIE behavior has been prepared by
introducing tetrakis(4-carboxyphenyl)ethylene acids 64 into
Fig. 51. Structure of 105 and Schematic illustration showing the formation of TD NPs. Spatial distributions of TPE NPs, DOX and TD NPs in MCF-7 s cells. (A) CLSM images of
TPE NPs, DOX and TD NPs and lysosomes, indicated by Lysotracker Green. (B) The breast cancer MCF-7 s cells were incubating with TPE NPs, DOX and TD NPs for 2 h. Detailed
TD NPs spatiotemporal distributions in MCF-7 s cells. Reproduced with permission from [182]. Copyright 2014 Wiley.
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ing ability of NCP-1–150 (150 stands for 150 mL of acetic acid) as
drug vehicle has been investigated by choosing Curcumin (Cur)
as model anticancer drug. UV–Vis absorption spectra (Fig. 54a)
with maximum at 425 nm represent the successful loading of
Cur, which is further supplemented with 1010 cm1 in FTIR spectra
accounted for stretching frequency of alcohol group from Cur
[187]. In-vitro drug release of Cur@NCP-1–150 in phosphate-
buffer saline (PBS) at 37 C is monitored at 7.4 and 5.0 pH values42(Fig. 54b). More than 53.7 % and 40.4 % of Cur are released from
Cur@NCP-1–150 in acidic and neutral PBS solution respectively
in 96 h. Good structural stability of NCP-1–150 is confirmed by
PXRD pattern of nanocarrier after drug release indicating the
nanoplatform suitability for efficient drug loading.
The significance of mechanically interlocked molecules like
rotaxane-based architectures for drug delivery has been well
explored by Guocan Yu and coworkers [188]. They have used sub-
stituted TPE 116 and triphenylphosphonium (TPP) 117 molecules
Fig. 52. Structure of 109 and Schematic illustration showing the Preparation Process of the DOX-Loaded FMSN@CuS (112). (A) In vitro viabilities of SGC-7901 cells after
incubation with different concentrations of free DOX, FMSN@CuS and DOX-loaded FMSN@CuS with or without NIR irradiation. B) Fluorescence microscope images of SGC-
7901 cells with various treatments stained with calcium-AM. Reproduced with permission from [183]. Copyright 2018 American Chemical Society.
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behaved as an AIE-active fluorogen in the synthesized rotaxane
R1, and TPP utilized as a mitochondria-targeting core. The AIE
effect of R1 is significantly better than the free axle, may be due
to the RIR of aromatic part of the TPE molecule upon [2]rotaxane
structure formation. The resulted rotaxane displayed excellent
photostability and specificity to target mitochondria. The prodrug
R2 (Fig. 55) was constructed by incorporating DOX into R1. R2
acted as dual-fluorescence-quenched Forster resonance energy
transfer system, in which TPE acted as the donor fluorophore and
DOX as acceptor. The fluorescences of the drug (DOX) and the car-43rier (R1) is recovered upon R2 hydrolysis in endo/lysosomes, dis-
playing a dual-color fluorogenic process. The escaped DOX and
R1 from endo/lysosomes, goes forward to nucleus and mitochon-
dria via cytoplasm, and crossed the mitochondrial and nuclear
membrane respectively. R1 was further utilized as a carrier to con-
jugate other amine functional anticancer drug (cytarabine
hydrochloride, temozolomide and gemcitabine) through imine for-
mation. The cytotoxic studies indicating the selective accumula-
tion of prodrug R2 in cancer cells (HeLa cells) over normal cells
(HEK293 cells) attributed to higher negative membrane potential
of cancer cells vs. normal cells.
Fig. 53. Structure of 113 and schematic representation of the ROS-sensitive nanoparticles (S-NPs) self-assembled from P(TPECM-AA-OEI)-g-Mpeg. (A) CLSM images of HeLa
cells stained with S-NPs/DNA (A1) and LysoTracker green (A2); overlay of the images A1 and A2 (A3); intensity profiles of region of interest (A4). (B) CLSM images of HeLa
cells incubated with S-NPs/YOYO-1-DNA complexes in the dark (B1), with light irradiation for 2 min (B2), 5 min (B3), and 5 min in the presence of VC (B4). Green: YOYO-1
fluorescence; Red: S-NPs. Yellow: colocalization of red and green pixels. (C) Changes in colocalization ratios between the fluorescence of YOYO-1 and S-NPs after different
treatment. (D,E) CLSM images of HeLa cells after incubation with D) S-NPs/YOYO-1-DNA pretreated with chloroquine (CQ), E) inS-NPs/ YOYO-1-DNA in the dark (D1, E1) or
after 5 min light irradiation (D2, E2). Reproduced with permission from [185]. Copyright 2015 Wiley.
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Fig. 54. Structure of 64 and schematic presentation of Zr-TCPE NCPs (115) synthesis and its application in drug delivery and cell imaging; Drug encapsulation and delivery of
NCP-1–150 nanoparticles. (a) UV–vis spectra of NCP-1–150 carriers, Cur@NCP-1–150 and free Cur molecules. (b) In vitro release profiles of Cur from Cur@NCP-1–150
nanocarriers at different PBS 7.4 and 5.0 at room temperature. Reproduced with permission from [186]. Copyright 2013 Royal Society of Chemistry.
Fig. 55. (Left) Synthetic route to R1 and chemical structures of some compounds. (Right) Schematic illustration of the preparation of a mitochondria-targeting probe-inspired
prodrug R2 and possible cellular pathways of the dual-fluorescence-quenched R2 nanoparticles. Reproduced with permission from [188]. Copyright 2016 Royal Society of
Chemistry.
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The development of materials with high fluorescent character-
istics in the solid and aggregated states has shown academic value
as well as the technological interest due to their implications in
biomolecular science. AIE is a nonconventional large polymer
molecule that emits fluorescence under UV irradiation in the
aggregated or solid-state. Such a phenomenon is reverse to con-
ventional fluorophore macromolecules, which quench their lumi-
nescence in the aggregation state. Moreover, the resultant of
conjugating AIE luminogens with biomolecules via covalent link-
age without reducing its fluorescence intensity is considered as
excellent candidate for various biomedical applications. These bio-
conjugates have shown all desired properties for biological appli-
cations such as biocompatibility, water solubility, specificity to
the target cells, and smart responsiveness. TPE is so far the most
studied AIE luminogen due to its mechanoluminescent properties
and it can quench the notorious ACQ property of the material that
is adverse for many applications.
In spite of remarkable advances in application of AIEgens in dis-
ease therapy and biosensing, there are some challenges that should
be addressed to direct future experiments for finding an effective
solution. The first drawback is attributed to preparation route of
AIEgens [178]. Designing a novel and easy method for AIE polymer
construction, preparation of AIEgens from photochemical and elec-
trochemical reactions as sustainable methods, and finding an easy
way for synthesis of NIR-II emissive AIEgens are among them
[178]. The next studies can focus on developing a novel strategy
for addressing aforementioned challenges. It is also worth men-
tioning that designing AIEgens with multifunctional application
can be achieved via embedding adjustable agents in AIE core that
can be the focus of future experiments.
As it was discussed in main text, AIEgens demonstrate lumines-
cence feature when they aggregate [189]. The luminescence char-
acteristic of AIEgens results from their twisted and nonplanar
shape, preventing their quenching in aggregation form. However,
their nonplanar shape avoids the ordered structure of AIEgens.
Besides, a wide variety of experiments have shown that AIEgens
can be applied for biosensing, detection of resistant pathogens
and tumor cells. Although it has been reported that AIEgens have
high biocompatibility and can provide live imaging, the cellular
uptake mechanism of AIEgens has not been completely investi-
gated. It has been shown that endocytosis is an important pathway
that AIEgens utilize in entering into cells. However, endocytosis
has different kinds including clathrin, caveolin, clathrin- and -
caveolae-independent endocytosis and phagocytosis. Now there
are some questions that come into mind. Which is the main endo-
cytic pathway for internalization of AIEgens? How cellular uptake
of AIEgens can be improved? And finally, various sizes of AIEgens
use which endocytic pathway for cellular internalization? Finding
an answer for these questions can pave the way for developing
more effective AIEgens, since these nanostructures have been
loaded with drugs that enhance their size and may challenge their
cellular uptake. The final issue that can be addressed, is use of AIE-
gens in bacterial detection. Increasing evidence has revealed
potential function of AIEgens in detecting Gram-positive and
Gram-negative bacteria due to interacting with surface via electro-
static or hydrophobic/hydrophilic interactions [190]. However,
clinical application of such AIEgens is restricted due to lack of
selective detection and imaging of certain bacteria (no specificity).
The increasing evidence (in vitro and in vivo) reveals high bio-
compatibility of AIEgens. The intravenous injection of AIEgens
leads to partial in vivo toxicity in mice, as major organs of body
(spleen, liver and kidney) have been examined and blood tests also46confirm high biocompatibility of these nanostructures. In terms of
clearance, AIEgens are mainly excreted by biliary pathway instead
of renal pathway. It has been reported that upon 9 days of AIEgens
injection, most of these nanoparticles will be present in feces with
partial existence in urine [191]. These features of AIEgens make
them appropriate options for clinical application. Furthermore, in
order to improve biocompatibility of AIEgens, their functionaliza-
tion with biomacromolecules including nucleic acids, peptides,
lipids and glycans is performed. The covalent bond, electrostatic
interaction and hydrophobic effect can mediate AIEgen functional-
ization with biomacromolecules. In addition to improving biocom-
patibility, such conjugation with biomacromolecules enhances
selectivity of AIEgens towards tumor cells [192].
Although AIEgens demonstrate high efficiency for imaging and
disease therapy, there are a number of inherent drawbacks includ-
ing short-wavelength absorption, broad emission spectrum and
nonoptimized emission that limit their biomedical uses. Fortu-
nately, some solutions have been addressed for aforementioned
issues. The multiphoton absorption, harmonic generation and
upconversion method are nonlinear optics phenomenon and
extensively applied in preparation of AIEgens via NIR light to over-
come limitations of AIEgens. In order to reduce emission band-
width of AIEgens and make it narrower, FERT, photonic crystals
and harmonic generation are involved in AIE system. The
bottom-up method is also suggested for improving brightness of
AIEgens and their water disparity [193].
In conclusion, we have focused on various TPE based AIE
luminogens and their potential application in biomedical science.
Many applications of these luminogens are yet to be exploited.
The present review aims to explore more excellent tetraphenyl
ethylene-AIE luminogens-based functional materials for the use
in biomedical areas such as cancer therapy, apoptosis and inflam-
mation, tumour targeting, microorganism imaging therapy, and
gene therapy etc and as well as other research areas.
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